N-CSRS 1 d928638dncsrs.htm N-CSRS N-CSRS
Table of Contents

As filed with the Securities and Exchange Commission on June 29, 2015

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM N-CSR

 

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-21597

 

 

PRIMECAP Odyssey Funds

(Exact name of registrant as specified in charter)

 

 

225 South Lake Avenue, Suite 400

Pasadena, CA 91101

(Address of principal executive offices) (Zip code)

 

 

Michael J. Ricks

PRIMECAP Management Company

225 South Lake Avenue, Suite 400

Pasadena, CA 91101

(Name and address of agent for service)

 

 

(626) 304-9222

Registrant’s telephone number, including area code

Date of fiscal year end: October 31

Date of reporting period: April 30, 2015

 

 

 


Table of Contents
Item 1. Reports to Stockholders.


Table of Contents

Item 1. Reports to Stockholders.

SEMIANNUAL REPORT

For the Six Months Ended April 30, 2015

 

LOGO

PRIMECAP ODYSSEY STOCK    (POSKX)

PRIMECAP ODYSSEY GROWTH (POGRX)

PRIMECAP ODYSSEY AGGRESSIVE GROWTH (POAGX)

 


Table of Contents
LOGO  

Table of Contents

PRIMECAP Odyssey Funds

 

Letter to Shareholders

     2   

Performance Graphs

     8   

PRIMECAP Odyssey Stock Fund

     8   

PRIMECAP Odyssey Growth Fund

     9   

PRIMECAP Odyssey Aggressive Growth Fund

     10   

Sector Breakdown

     11   

Schedule of Investments

     13   

PRIMECAP Odyssey Stock Fund

     13   

PRIMECAP Odyssey Growth Fund

     17   

PRIMECAP Odyssey Aggressive Growth Fund

     22   

Statements of Assets and Liabilities

     27   

Statements of Operations

     28   

Statements of Changes in Net Assets

     29   

PRIMECAP Odyssey Stock Fund

     29   

PRIMECAP Odyssey Growth Fund

     30   

PRIMECAP Odyssey Aggressive Growth Fund

     31   

Financial Highlights

     32   

PRIMECAP Odyssey Stock Fund

     32   

PRIMECAP Odyssey Growth Fund

     33   

PRIMECAP Odyssey Aggressive Growth Fund

     34   

Notes to Financial Statements

     35   

Expense Example

     43   

Additional Information

     45   

Management

     46   

Privacy Notice

  

 

1


Table of Contents
LOGO  

Letter to Shareholders

PRIMECAP Odyssey Funds

 

Dear Fellow Shareholders,

For the six months ended April 30, 2015, the PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund produced total returns of +5.90%, +5.14%, and +9.18%, respectively, in each case ahead of the +4.40% total return of the unmanaged S&P 500.

The U.S. economy continued to expand during the period, though at a decelerating rate. After growing by 4.6% and 5.0% in the second and third quarters of 2014, respectively, real GDP growth slowed to 2.2% in the fourth quarter of 2014 and 0.2% in the first quarter of 2015. The labor market continued to improve, with the unemployment rate declining to 5.4% at the end of April, the lowest level since May 2008. Lower energy prices resulted in consumer price declines for three months beginning in November 2014. While consumer prices rebounded in February and March, they remained slightly lower on a year-over-year basis. Excluding food and energy, inflation remained subdued.

After declining precipitously from nearly $100 per barrel in July 2014 to $50 in January 2015, crude oil prices partially rebounded to $60 in April. According to the U.S. Energy Information Agency, domestic oil production began to stabilize at approximately 9.2 million barrels per day in early 2015, the highest level since 1973. The number of active U.S. oil drilling rigs declined by over 50% during the period in response to lower oil prices.

The Federal Reserve continued to tighten U.S. monetary policy by concluding its monthly bond purchases in October, though the central bank is expected to maintain very low short-term interest rates for a considerable time. In other major economies, notably the Eurozone and China, central banks loosened monetary policy, with the European Central Bank introducing its first quantitative easing program. The U.S. dollar strengthened significantly relative to the Euro and other major currencies during the period.

The S&P 500 continued to appreciate and reached an all-time high towards the end of the period. Stocks with higher price-to-earnings ratios and higher forecasted growth rates outperformed stocks with lower price-to-earnings ratios and lower forecasted growth rates. The energy sector was the worst-performing sector during the period, driven by lower oil prices, while the consumer discretionary sector was the best-performing sector.

Each of the PRIMECAP Odyssey Funds continues to be overweight in the health care and information technology sectors, and underweight in the financials, consumer staples, energy, materials, utilities, and telecommunication services sectors.

A more detailed discussion of the results of each PRIMECAP Odyssey Fund follows.

PRIMECAP Odyssey Stock Fund

From November 1, 2014 to April 30, 2015, the Stock Fund’s total return of +5.90% exceeded the S&P 500’s total return of +4.40%.

 

2


Table of Contents

Letter to Shareholders

PRIMECAP Odyssey Funds

 

continued

 

Favorable stock selection in the consumer discretionary, industrials, and financials sectors was partially offset by unfavorable stock selection in the health care, information technology, and energy sectors. Sector allocations had a net positive impact on the fund’s relative results, led by an underweight position in energy, the worst-performing sector for the period, overweight positions in health care and information technology, and underweight positions in utilities and financials.

In the consumer discretionary sector, the fund’s outperformance was primarily attributable to Sony (+53%), L Brands (+28%), Ross Stores (+23%), and Ascena Retail Group (+20%), while in the industrials sector, outperformance was driven by Southwest Airlines (+18%) and Airbus (+16%). CME Group (+12%) was the most important contributor in the financials sector. These positives were partially offset by unfavorable selection in health care, where two of the fund’s largest holdings, Amgen (-2%) and Roche (+1%), underperformed, as well as unfavorable selection in energy, notably Transocean (-32%). In information technology, significant gains in several stocks, including Analog Devices (+26%), Altera (+23%), Cisco Systems (+20%), and Texas Instruments (+11%), were offset by losses in NetApp (-15%), Hewlett-Packard (-7%), and Ericsson (-6%). Not owning Apple (+17%) was the single biggest detractor from the fund’s results in the information technology sector.

The top 10 holdings, which collectively represented 25.0% of the portfolio at the period end, are listed below:

 

PRIMECAP Odyssey Stock Fund

Top 10 Holdings as of 4/30/15

   Ending % of
Total Portfolio*
 

Eli Lilly & Co.

     3.8   

Roche Holding AG

     2.9   

Amgen Inc.

     2.8   

Carnival Corp.

     2.5   

eBay Inc.

     2.3   

Charles Schwab Corp.

     2.3   

Airbus Group NV

     2.2   

Sony Corp. Sponsored ADR

     2.2   

L Brands, Inc.

     2.0   

Southwest Airlines Co.

     2.0   

Total % of Portfolio

     25.0 % 

 

  * The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

 

3


Table of Contents

Letter to Shareholders

PRIMECAP Odyssey Funds

 

continued

 

PRIMECAP Odyssey Growth Fund

From November 1, 2014 to April 30, 2015, the Growth Fund’s total return was +5.14%, ahead of the S&P 500’s total return of +4.40%, but below the Russell 1000 Growth Index’s total return of +6.54%.

Unfavorable stock selection in the information technology, health care, and energy sectors detracted from the fund’s results and was only partially offset by favorable stock selection in the consumer discretionary, industrials, and financials sectors. Sector allocations, including underweight positions in energy, financials, and utilities, as well as overweight positions in health care and information technology, added to the fund’s relative returns. In information technology, losses in Stratasys (-69%), SanDisk (-28%), and NetApp (-15%) were only partially offset by gains in Ellie Mae (+43%) and Electronic Arts (+42%). Not owning Apple (+17%) also had a significant negative impact on the fund’s relative results. In health care, Nektar Therapeutics (-31%), Insulet (-31%), and Seattle Genetics (-6%) detracted from the fund’s performance, while ABIOMED (+93%) and Biogen (+16%) were the most significant positive contributors. Losses in Transocean (-32%) led to underperformance in the energy sector. These negatives were partially offset by strong performance in consumer discretionary, where Sony (+53%), L Brands (+28%), Norwegian Cruise Line (+24%), and CarMax (+22%) had the largest positive impact. Outperformance in industrials was largely driven by the fund’s airline holdings, including JetBlue Airways (+78%), Southwest Airlines (+18%), American Airlines Group (+17%), and United Continental Holdings (+13%). E*TRADE Financial (+29%) was the largest positive contributor in the financials sector.

The top 10 holdings, which collectively represented 26.9% of the portfolio at the period end, are listed below:

 

PRIMECAP Odyssey Growth Fund

Top 10 Holdings as of 4/30/15

   Ending % of
Total Portfolio*
 

Amgen Inc.

     3.6   

Eli Lilly & Co.

     3.6   

Roche Holding AG

     3.0   

Seattle Genetics, Inc.

     2.9   

Biogen Inc.

     2.9   

L Brands, Inc.

     2.5   

Google Inc.

     2.2   

ABIOMED, Inc.

     2.1   

Microsoft Corp.

     2.1   

Adobe Systems Inc.

     2.0   

Total % of Portfolio

     26.9 % 

 

  * The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

 

4


Table of Contents

Letter to Shareholders

PRIMECAP Odyssey Funds

 

continued

 

PRIMECAP Odyssey Aggressive Growth Fund

From November 1, 2014 to April 30, 2015, the Aggressive Growth Fund’s total return of +9.18% exceeded the S&P 500’s total return of +4.40% and the Russell Midcap Growth Index’s total return of +7.77%.

Stock selection contributed nearly twice as much as sector allocations to the fund’s outperformance relative to the S&P 500. Strong stock selection in health care, industrials, and financials was partially offset by unfavorable stock selection in information technology and energy. In health care, gains in Pharmacyclics (+96%), Dyax (+93%), and ABIOMED (+93%) were partially offset by losses in Epizyme (-39%) and Nektar Therapeutics (-31%). In industrials, the fund’s airline holdings, including JetBlue Airways (+78%), Alaska Air Group (+21%), American Airlines Group (+17%), United Continental Holdings (+13%), and Delta Air Lines (+11%), accounted for most of the fund’s outperformance. Polypore International (+33%) also made a significant positive contribution to the fund’s relative results in the industrials sector, while MarketAxess Holdings (+33%) favorably impacted the fund’s relative results in the financials sector. These positives were offset by unfavorable stock selection in information technology, where losses in Stratasys (-69%), FARO Technologies (-29%), SanDisk (-28%), and Micron (-15%) were only partially offset by gains in Ellie Mae (+43%) and comScore (+24%). Not owning Apple (+17%) also had a significant negative impact on the fund’s relative results. Solazyme (-50%) and Transocean (-32%) were the biggest detractors from the fund’s relative returns in the energy sector. The fund also benefited from sector allocations due to its underweight positions in energy, financials, and utilities, as well as its overweight positions in health care, information technology, and consumer discretionary.

The top 10 holdings, which collectively represented 28.7% of the portfolio at the period end, are listed below:

 

PRIMECAP Odyssey Aggressive Growth Fund

Top 10 Holdings as of 4/30/15

   Ending % of
Total Portfolio*
 

Pharmacyclics, Inc.

     4.5   

Sony Corp. Sponsored ADR

     3.3   

Polypore International, Inc.

     3.0   

United Continental Holdings, Inc.

     2.8   

Blackberry Ltd.

     2.8   

Dyax Corp.

     2.7   

comScore, Inc.

     2.7   

ABIOMED, Inc.

     2.4   

American Airlines Group, Inc.

     2.3   

Ellie Mae, Inc.

     2.2   

Total % of Portfolio

     28.7 % 

 

  * The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

 

5


Table of Contents

Letter to Shareholders

PRIMECAP Odyssey Funds

 

continued

 

Outlook for U.S. equities

Looking ahead, we are less constructive on the outlook for U.S. equities than we have been in recent years, though we continue to believe that many individual stocks are attractively valued and that stocks represent a more attractive investment than bonds at current prices. As of April 30, 2015, the S&P 500 was trading for approximately 17.4x 2015 consensus estimated earnings per share of $120, a higher level than the average over the past 15 years. S&P 500 consensus estimates have been reduced since the end of last year, primarily due to extensive downward revisions in the energy and materials sectors. Sales and earnings per share for the energy sector are now expected to decline by 32% and 56%, respectively, in 2015. Largely as a result of these declines, overall sales for the S&P 500 in 2015 are expected to decline by 2%, while earnings per share are expected to increase by 2%. S&P 500 consensus estimates assume a sharp rebound in 2016, with both sales and earnings per share expected to grow at the fastest rates since 2011.

Portfolio update and outlook

The funds remain significantly overweight in health care. We remain confident in the fundamental long-term outlook for the health care industry. Increasing worldwide demand for health care products will be driven by demographic trends as well as the industry’s ability to develop new and more effective therapies for a wide range of diseases and health conditions. For example, Biogen recently reported positive data in an early-stage trial studying its drug for Alzheimer’s disease. These data rekindled both researcher and investor enthusiasm in the potential of this class of drug to treat Alzheimer’s. Eli Lilly has a similar, promising drug in late-stage clinical trials. Another area of tremendous progress is the treatment of hepatitis C virus (HCV) liver infection. Five years ago, the standard treatment for this deadly disease consisted of a year-long regimen including hard-to-tolerate weekly injections; the resulting cure rate was in the 50% range. Recently, Gilead and Abbvie received FDA approval for their all-oral HCV therapies, which achieved cure rates of >90% in as few as 8 to 12 weeks of treatment, and further improvements are on the horizon.

While our long-term outlook for health care is positive, it is tempered by increasing concerns related to reimbursement and pricing for approved drugs and biologics. Payors recently have been able to extract higher-than-expected pricing concessions from Abbvie and Gilead as they competed for share with their new HCV drugs. This has resulted in investor concern that pricing pressure may similarly make its way into other therapeutic areas, such as diabetes, rheumatoid arthritis, and multiple sclerosis. Ultimately, we feel that high-value therapies that are unique in the market and substantially improve patient outcomes will continue to garner favorable pricing from reimbursement authorities. As we think ahead to our stock positioning in health care, we will focus to an even greater extent on the more innovative bio/pharma companies with differentiated pipelines. Given the uncertain pricing outlook, we feel that it may be harder for the large biotech and pharmaceutical groups to continue their relative outperformance. Increasingly, we are seeing more attractive opportunities in other health care areas, such as life science research tools and diagnostics.

The funds also have significant investments in the airline industry, which we believe to be an attractive area for equity investment in spite of the group’s recent outperformance. The industry has consolidated significantly over the past decade, and today the four largest airlines comprise roughly 85%

 

6


Table of Contents

Letter to Shareholders

PRIMECAP Odyssey Funds

 

continued

 

of industry capacity. Capacity has been reduced by 9% since 2007, and utilization is at historically high levels, which has provided the airlines with the opportunity to raise ticket prices. Furthermore, the industry has established new, high-margin ancillary revenue streams, which are becoming meaningful drivers of profitability. Finally, the recent drop in crude oil prices represents a tailwind to the airlines as jet fuel represents roughly 25% of an airline’s costs, on average.

In conclusion, we remain committed to our investment philosophy, which is to invest in attractively priced individual stocks for the long term. This “bottom-up” approach often results in portfolios that bear little resemblance to market indices; therefore, our results often deviate substantially from such indices. Furthermore, our long-term investment horizon results in low portfolio turnover, which creates the possibility for extended periods of underperformance when the stocks in our portfolio fall out of favor. We nonetheless believe that this approach can generate superior results for investors over the long term.

Sincerely,

PRIMECAP Management Company

May 15, 2015

Past performance is not a guarantee of future results.

The funds invest in smaller companies, which involve additional risks such as limited liquidity and greater volatility. All funds may invest in foreign securities, which involves: 1) greater volatility; 2) political, economic, and currency risks; and 3) differences in accounting methods. Mutual fund investing involves risk, and loss of principal is possible. Growth stocks typically are more volatile than value stocks; however, value stocks have a lower expected growth rate in earnings and sales.

Please refer to the Schedule of Investments for details of fund holdings. Fund holdings and sector allocations are subject to change at any time and are not recommendations to buy or sell any security.

The S&P 500 is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market. The Russell 1000 Growth Index is an index that measures the performance of those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values (the Russell 1000 Index measures the performance of the large-cap segment of the U.S. equity universe). The Russell Midcap Growth Index measures the performance of those Russell Midcap companies with higher price-to-book ratios and higher forecasted growth values. You cannot invest directly in an index.

Price-to-earnings ratio is calculated by dividing the current share price of a stock by its earnings per share.

Earnings per share is calculated by taking the total earnings divided by the number of shares outstanding.

Earnings growth is not a prediction of a fund’s future performance.

The information provided herein represents the opinions of PRIMECAP Management Company and is not intended to be a forecast of future events, a guarantee of future results, or investment advice.

 

7


Table of Contents
LOGO  

Performance Graphs

PRIMECAP Odyssey Stock Fund

 

The following chart compares the value of a hypothetical $10,000 investment in the PRIMECAP Odyssey Stock Fund from November 1, 2004 (inception) to April 30, 2015, compared to the S&P 500. This chart illustrates the performance of a hypothetical $10,000 investment made on the fund’s inception date and is not intended to imply any future performance. The returns shown do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The chart assumes reinvestment of capital gains and dividends.

 

LOGO

 

      Total Return
Period Ended April 30, 2015
 
      1 Year      Annualized
5 Year
     Annualized
10 Year
     Annualized
Since Inception^
 

Stock Fund

     14.75%         14.08%         10.02%         10.03%   

S&P 500*

     12.98%         14.33%         8.32%         8.24%   

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the fund may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling 1-800-729-2307.

 

  * The S&P 500 is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.
  ^ November 1, 2004

 

8


Table of Contents
LOGO  

Performance Graphs

PRIMECAP Odyssey Growth Fund

 

The following chart compares the value of a hypothetical $10,000 investment in the PRIMECAP Odyssey Growth Fund from November 1, 2004 (inception) to April 30, 2015, compared to the S&P 500. This chart illustrates the performance of a hypothetical $10,000 investment made on the fund’s inception date and is not intended to imply any future performance. The returns shown do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The chart assumes reinvestment of capital gains and dividends.

 

LOGO

 

      Total Return
Period Ended April 30, 2015
 
      1 Year      Annualized
5 Year
     Annualized
10 Year
     Annualized
Since Inception^
 

Growth Fund

     16.21%         14.41%         10.82%         10.75%   

S&P 500*

     12.98%         14.33%         8.32%         8.24%   

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the fund may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling 1-800-729-2307.

 

  * The S&P 500 is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.
  ^ November 1, 2004

 

9


Table of Contents
LOGO  

Performance Graphs

PRIMECAP Odyssey Aggressive Growth Fund

 

The following chart compares the value of a hypothetical $10,000 investment in the PRIMECAP Odyssey Aggressive Growth Fund from November 1, 2004 (inception) to April 30, 2015, compared to the S&P 500. This chart illustrates the performance of a hypothetical $10,000 investment made on the fund’s inception date and is not intended to imply any future performance. The returns shown do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The chart assumes reinvestment of capital gains and dividends.

 

LOGO

 

     Total Return
Period Ended April 30, 2015
 
     1 Year      Annualized
5 Year
     Annualized
10 Year
     Annualized
Since Inception^
 

Aggressive Growth Fund

    22.87%         19.64%         14.90%         14.03%   

S&P 500*

    12.98%         14.33%         8.32%         8.24%   

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the fund may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling 1-800-729-2307.

 

  * The S&P 500 is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.
  ^ November 1, 2004

 

10


Table of Contents
LOGO  

Sector Breakdown

PRIMECAP Odyssey Funds

 

PRIMECAP Odyssey Stock Fund

 

Consumer Discretionary

     13.9%   

Consumer Staples

     1.1%   

Energy

     1.5%   

Financials

     10.8%   

Health Care

     22.7%   

Industrials

     11.4%   

Information Technology

     27.8%   

Materials

     2.4%   

Utilities

     0.3%   

Short-Term Investments, net of Other Liabilities

     8.1%   

Total

     100.0%   

PRIMECAP Odyssey Growth Fund

 

Consumer Discretionary

     13.0%   

Consumer Staples

     0.5%   

Energy

     1.1%   

Financials

     5.3%   

Health Care

     32.9%   

Industrials

     9.7%   

Information Technology

     28.4%   

Materials

     1.0%   

Short-Term Investments, net of Other Liabilities

     8.1%   

Total

     100.0%   

The tables above list sector allocations as a percentage of each fund’s total net assets as of April 30, 2015. The management report may make reference to average allocations during the period. As a result, the sector allocations above may differ from those discussed in the management report.

 

11


Table of Contents

Sector Breakdown

PRIMECAP Odyssey Funds

 

continued

 

PRIMECAP Odyssey Aggressive Growth Fund

 

Consumer Discretionary

     15.7%   

Consumer Staples

     0.5%   

Energy

     1.4%   

Financials

     2.4%   

Health Care

     32.8%   

Industrials

     16.6%   

Information Technology

     27.8%   

Materials

     0.6%   

Telecommunication Services

     1.2%   

Short-Term Investments, net of Other Liabilities

     1.0%   

Total

     100.0%   

The table above lists sector allocations as a percentage of the fund’s total net assets as of April 30, 2015. The management report may make reference to average allocations during the period. As a result, the sector allocations above may differ from those discussed in the management report.

 

12


Table of Contents
LOGO  

Schedule of Investments

PRIMECAP Odyssey Stock Fund

April 30, 2015 (Unaudited)

 

Shares            Value  
  COMMON STOCKS – 91.9%   
Consumer Discretionary – 13.9%       
  4,100,000      

Ascena Retail Group, Inc. (a)

   $ 61,459,000   
  73,200      

Bed Bath & Beyond, Inc. (a)

     5,157,672   
  246,600      

CarMax, Inc. (a)

     16,795,926   
  2,524,600      

Carnival Corp.

     111,006,662   
  54,900      

DIRECTV (a)

     4,979,705   
  1,009,137      

L Brands, Inc.

     90,176,482   
  60,000      

Newell Rubbermaid, Inc.

     2,287,800   
  661,000      

Ross Stores, Inc.

     65,359,680   
  70,000      

Royal Caribbean Cruises Ltd.

     4,764,200   
  3,150,000      

Sony Corp. – ADR

     95,224,500   
  193,400      

TJX Cos., Inc.

     12,482,036   
  1,000,300      

Tribune Media Co. – Class A

     56,086,821   
  1,816,600      

Tribune Publishing Co. (b)

     31,917,662   
  624,806      

Urban Outfitters, Inc. (a)

     25,017,232   
  225,000      

Walt Disney Co. (The)

     24,462,000   
  22,100      

Whirlpool Corp.

     3,880,760   
     

 

 

 
        611,058,138   
     

 

 

 
Consumer Staples – 1.1%       
  166,000      

CVS Health Corp.

     16,482,140   
  70,000      

Kellogg Co.

     4,433,100   
  150,000      

PepsiCo, Inc.

     14,268,000   
  315,000      

Tyson Foods, Inc. – Class A

     12,442,500   
     

 

 

 
        47,625,740   
     

 

 

 
Energy – 1.5%       
  235,000      

Cameron International Corp. (a)

     12,882,700   
  30,000      

EOG Resources, Inc.

     2,968,500   
  95,000      

Exxon Mobil Corp.

     8,300,150   
  45,000      

National Oilwell Varco, Inc.

     2,448,450   
  60,000      

Range Resources Corp.

     3,813,600   
  141,534      

Schlumberger Ltd.

     13,390,532   
  100,500      

Southwestern Energy Co. (a)

     2,817,015   
  1,072,000      

Transocean Ltd.

     20,175,040   
     

 

 

 
        66,795,987   
     

 

 

 
Financials – 10.8%       
  75,000      

American Express Co.

     5,808,750   
  3,309,900      

Charles Schwab Corp. (The)

     100,951,950   
  70,000      

Chubb Corp. (The)

     6,884,500   
  701,100      

CME Group, Inc.

     63,737,001   

 

The accompanying notes are an integral part of these financial statements.

 

13


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Stock Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Financials (continued)       
  257,000      

Comerica, Inc.

   $ 12,184,370   
  337,200      

Discover Financial Services

     19,547,484   
  1,322,900      

JPMorgan Chase & Co.

     83,686,654   
  684,950      

Marsh & McLennan Cos., Inc.

     38,466,792   
  281,600      

Mercury General Corp.

     15,471,104   
  1,153,600      

Progressive Corp. (The)

     30,754,976   
  1,493,908      

Wells Fargo & Co.

     82,314,331   
  348,200      

Willis Group Holdings PLC

     16,932,966   
     

 

 

 
        476,740,878   
     

 

 

 
Health Care – 22.7%       
  1,020,900      

Abbott Laboratories

     47,390,178   
  600,200      

AbbVie, Inc.

     38,808,932   
  75,000      

Affymetrix, Inc. (a)

     909,750   
  1,257,000      

Agilent Technologies, Inc.

     52,002,090   
  783,500      

Amgen, Inc.

     123,722,485   
  144,600      

Biogen, Inc. (a)

     54,070,278   
  117,900      

Boston Scientific Corp. (a)

     2,100,978   
  2,311,400      

Eli Lilly & Co.

     166,120,318   
  266,735      

GlaxoSmithKline PLC – ADR

     12,309,820   
  828,400      

Johnson & Johnson

     82,177,280   
  569,600      

Medtronic PLC

     42,406,720   
  1,210,000      

Merck & Co., Inc.

     72,067,600   
  518,350      

Novartis AG – ADR

     52,768,030   
  1,008,391      

PerkinElmer, Inc.

     51,690,123   
  435,044      

Roche Holding AG – CHF

     125,623,939   
  480,000      

Sanofi – ADR

     24,264,000   
  392,000      

Thermo Fisher Scientific, Inc.

     49,266,560   
     

 

 

 
        997,699,081   
     

 

 

 
Industrials – 11.4%       
  1,388,500      

Airbus Group N.V. – EUR

     96,662,886   
  95,200      

Alaska Air Group, Inc.

     6,098,512   
  186,800      

Boeing Co. (The)

     26,775,912   
  154,000      

C.H. Robinson Worldwide, Inc.

     9,916,060   
  156,000      

Caterpillar, Inc.

     13,553,280   
  245,000      

CSX Corp.

     8,842,050   
  365,000      

Curtiss-Wright Corp.

     26,666,900   
  411,619      

Deere & Co.

     37,259,752   
  201,900      

FedEx Corp.

     34,236,183   
  266,550      

Honeywell International, Inc.

     26,900,226   

 

The accompanying notes are an integral part of these financial statements.

 

14


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Stock Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Industrials (continued)       
  302,800      

Jacobs Engineering Group, Inc. (a)

   $ 12,978,008   
  199,761      

Matson, Inc.

     8,090,321   
  232,000      

Norfolk Southern Corp.

     23,397,200   
  190,000      

Pentair PLC

     11,808,500   
  100,000      

Republic Services, Inc.

     4,063,000   
  644,700      

Ritchie Bros. Auctioneers, Inc.

     16,304,463   
  97,000      

Rockwell Automation, Inc.

     11,504,200   
  157,600      

Safran S.A. – EUR

     11,546,727   
  2,209,200      

Southwest Airlines Co.

     89,605,152   
  181,700      

United Parcel Service, Inc. – Class B

     18,266,301   
  56,000      

United Technologies Corp.

     6,370,000   
     

 

 

 
        500,845,633   
     

 

 

 
Information Technology – 27.8%       
  1,040,000      

Activision Blizzard, Inc.

     23,727,600   
  509,600      

Adobe Systems, Inc. (a)

     38,760,176   
  1,110,830      

Altera Corp.

     46,299,394   
  611,800      

Analog Devices, Inc.

     37,833,712   
  955,000      

Applied Materials, Inc.

     18,899,450   
  440,000      

Broadcom Corp. – Class A

     19,450,200   
  2,556,600      

Cisco Systems, Inc.

     73,706,778   
  750,000      

Corning, Inc.

     15,697,500   
  485,000      

Diebold, Inc.

     16,863,450   
  1,750,000      

eBay, Inc. (a)

     101,955,000   
  638,700      

EMC Corp.

     17,187,417   
  21,900      

Google, Inc. – Class A (a)

     12,018,063   
  27,977      

Google, Inc. – Class C (a)

     15,032,946   
  1,871,200      

Hewlett-Packard Co.

     61,693,464   
  1,449,600      

Intel Corp.

     47,184,480   
  39,100      

Intuit, Inc.

     3,922,903   
  2,006,800      

Keysight Technologies, Inc. (a)

     67,147,528   
  726,500      

KLA-Tencor Corp.

     42,718,200   
  6,577,900      

L.M. Ericsson Telephone Co. – ADR

     71,830,668   
  49,000      

MasterCard, Inc. – Class A

     4,420,290   
  1,823,100      

Microsoft Corp.

     88,675,584   
  2,258,400      

NetApp, Inc.

     81,867,000   
  1,534,924      

NeuStar, Inc. – Class A (a)

     46,047,720   
  545,000      

NVIDIA Corp.

     12,096,275   
  775,905      

QUALCOMM, Inc.

     52,761,540   
  429,300      

SanDisk Corp.

     28,737,342   

 

The accompanying notes are an integral part of these financial statements.

 

15


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Stock Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Information Technology (continued)       
  270,000      

Symantec Corp.

   $ 6,729,750   
  1,632,800      

Texas Instruments, Inc.

     88,514,088   
  200,000      

Thomson Reuters Corp.

     8,212,000   
  396,400      

Visa, Inc. – Class A

     26,182,220   
  1,130,000      

Yahoo!, Inc. (a)

     48,098,450   
     

 

 

 
        1,224,271,188   
     

 

 

 
Materials – 2.4%       
  340,000      

Celanese Corp. – Series A

     22,562,400   
  429,700      

Dow Chemical Co. (The)

     21,914,700   
  157,800      

E.I. du Pont de Nemours and Co.

     11,550,960   
  70,000      

Greif, Inc. – Class A

     2,853,200   
  31,968      

Greif, Inc. – Class B

     1,528,070   
  25,000      

LyondellBasell Industries N.V. – Class A

     2,588,000   
  135,900      

Monsanto Co.

     15,487,164   
  136,900      

Potash Corp. of Saskatchewan, Inc.

     4,468,416   
  481,200      

Schweitzer-Mauduit International, Inc.

     21,273,852   
     

 

 

 
        104,226,762   
     

 

 

 
Utilities – 0.3%       
  372,379      

Public Service Enterprise Group, Inc.

     15,468,624   
     

 

 

 

 
 

TOTAL COMMON STOCKS
(Cost $2,963,811,625)

   $ 4,044,732,031   
     

 

 

 
SHORT-TERM INVESTMENTS – 8.1%       
  357,473,912      

Dreyfus Treasury Prime Cash Management Fund

     357,473,912   
     

 

 

 

 
 

TOTAL SHORT-TERM INVESTMENTS
(Cost $357,473,912)

     357,473,912   
     

 

 

 

 
 

TOTAL INVESTMENTS
(Cost $3,321,285,537) – 100.0%

     4,402,205,943   

 

Liabilities in Excess of Other Assets – (0.0)%

     (734,577 ) 
     

 

 

 

 

TOTAL NET ASSETS – 100.0%

   $ 4,401,471,366   
     

 

 

 

 

ADR  American Depository Receipt

CHF  Swiss Francs

EUR  Euros

(a) Non-Income Producing
(b) Considered an affiliated company of the fund as the fund owns 5% or more of the outstanding voting securities of such company.

The Global Industry Classification Standard (GICS®) was developed by and is the exclusive property of MSCI Inc. and Standard & Poor's Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by the fund's administrator.

 

The accompanying notes are an integral part of these financial statements.

 

16


Table of Contents
LOGO  

Schedule of Investments

PRIMECAP Odyssey Growth Fund

April 30, 2015 (Unaudited)

 

Shares            Value  
  COMMON STOCKS – 91.9%   
Consumer Discretionary – 13.0%       
  2,145,000      

Ascena Retail Group, Inc. (a)

   $ 32,153,550   
  154,200      

Bed Bath & Beyond, Inc. (a)

     10,864,932   
  963,215      

CarMax, Inc. (a)

     65,604,574   
  1,975,746      

Carnival Corp.

     86,873,552   
  161,800      

DIRECTV (a)

     14,676,069   
  2,750,000      

DreamWorks Animation SKG, Inc. – Class A (a)

     71,665,000   
  568,300      

Gildan Activewear, Inc.

     18,020,793   
  1,577,398      

L Brands, Inc.

     140,956,285   
  1,674,600      

Norwegian Cruise Line Holdings Ltd. (a)

     81,234,846   
  68,000      

Ross Stores, Inc.

     6,723,840   
  185,000      

Royal Caribbean Cruises Ltd.

     12,591,100   
  4,100      

Shake Shack, Inc. – Class A (a)

     281,875   
  1,532,700      

Shutterfly, Inc. (a)

     68,603,652   
  3,695,000      

Sony Corp. – ADR

     111,699,850   
  126,000      

TJX Cos., Inc.

     8,132,040   
  308,600      

Urban Outfitters, Inc. (a)

     12,356,344   
     

 

 

 
        742,438,302   
     

 

 

 
Consumer Staples – 0.5%  
  1,588,411      

Boulder Brands, Inc. (a)

     15,153,441   
  152,000      

CVS Health Corp.

     15,092,080   
     

 

 

 
        30,245,521   
     

 

 

 
Energy – 1.1%  
  115,000      

EOG Resources, Inc.

     11,379,250   
  215,000      

Frank's International N.V.

     4,472,000   
  70,000      

National Oilwell Varco, Inc.

     3,808,700   
  100,000      

Range Resources Corp.

     6,356,000   
  104,300      

Schlumberger Ltd.

     9,867,823   
  215,000      

Southwestern Energy Co. (a)

     6,026,450   
  1,180,400      

Transocean Ltd.

     22,215,128   
     

 

 

 
        64,125,351   
     

 

 

 
Financials – 5.3%  
  3,695,223      

Charles Schwab Corp. (The)

     112,704,301   
  100,000      

Chubb Corp. (The)

     9,835,000   
  107,000      

CME Group, Inc.

     9,727,370   
  202,214      

Discover Financial Services

     11,722,346   
  2,896,400      

E*TRADE Financial Corp. (a)

     83,387,356   
  71,000      

JPMorgan Chase & Co.

     4,491,460   
  540,350      

Marsh & McLennan Cos., Inc.

     30,346,056   

 

The accompanying notes are an integral part of these financial statements.

 

17


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Financials (continued)  
  408,000      

Progressive Corp. (The)

   $ 10,877,280   
  500,000      

Wells Fargo & Co.

     27,550,000   
     

 

 

 
        300,641,169   
     

 

 

 
Health Care – 32.9%  
  852,018      

Abbott Laboratories

     39,550,676   
  1,934,800      

ABIOMED, Inc. (a)

     122,318,056   
  3,623,600      

Accuray, Inc. (a)

     29,459,868   
  950,000      

Affymetrix, Inc. (a)

     11,523,500   
  294,300      

Agilent Technologies, Inc.

     12,175,191   
  1,313,800      

Amgen, Inc.

     207,462,158   
  440,200      

Biogen, Inc. (a)

     164,603,986   
  370,200      

BioMarin Pharmaceutical, Inc. (a)

     41,480,910   
  1,058,800      

Boston Scientific Corp. (a)

     18,867,816   
  995,100      

Cepheid, Inc. (a)

     55,825,110   
  193,700      

Charles River Laboratories International, Inc. (a)

     13,396,292   
  30,000      

Dyax Corp. (a)

     717,300   
  2,836,651      

Eli Lilly & Co.

     203,870,107   
  2,045,143      

Epizyme, Inc. (a)

     33,356,282   
  463,400      

Illumina, Inc. (a)

     85,381,450   
  6,550,854      

ImmunoGen, Inc. (a) (b)

     54,175,563   
  1,911,180      

Insulet Corp. (a)

     57,048,723   
  583,537      

Johnson & Johnson

     57,886,870   
  494,150      

Medtronic PLC

     36,789,468   
  565,000      

Merck & Co., Inc.

     33,651,400   
  550,000      

Momenta Pharmaceuticals, Inc. (a)

     9,597,500   
  5,600,356      

Nektar Therapeutics (a)

     53,315,389   
  516,750      

Novartis AG – ADR

     52,605,150   
  220,000      

NuVasive, Inc. (a)

     9,840,600   
  433,000      

OraSure Technologies, Inc. (a)

     2,727,900   
  276,300      

PerkinElmer, Inc.

     14,163,138   
  3,513,716      

QIAGEN N.V. (a)

     83,661,578   
  586,500      

Roche Holding AG – CHF

     169,358,594   
  4,926,900      

Seattle Genetics, Inc. (a)

     169,189,746   
  184,400      

Thermo Fisher Scientific, Inc.

     23,175,392   
  118,500      

Waters Corp. (a)

     14,835,015   
     

 

 

 
        1,882,010,728   
     

 

 

 
Industrials – 9.7%  
  630,300      

AECOM (a)

     19,892,268   
  737,700      

Airbus Group N.V. – EUR

     51,356,292   

 

The accompanying notes are an integral part of these financial statements.

 

18


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Industrials (continued)  
  1,544,000      

American Airlines Group, Inc.

   $ 74,552,040   
  176,000      

C.H. Robinson Worldwide, Inc.

     11,332,640   
  133,600      

Caterpillar, Inc.

     11,607,168   
  146,000      

CIRCOR International, Inc.

     7,977,440   
  259,000      

Curtiss-Wright Corp.

     18,922,540   
  1,150,000      

Delta Air Lines, Inc.

     51,336,000   
  170,000      

Expeditors International of Washington, Inc.

     7,791,100   
  40,900      

FedEx Corp.

     6,935,413   
  177,000      

IDEX Corp.

     13,276,770   
  741,594      

Jacobs Engineering Group, Inc. (a)

     31,784,719   
  1,227,550      

JetBlue Airways Corp. (a)

     25,201,601   
  40,000      

Pall Corp.

     3,892,800   
  489,000      

Ritchie Bros. Auctioneers, Inc.

     12,366,810   
  33,100      

Rockwell Automation, Inc.

     3,925,660   
  2,823,200      

Southwest Airlines Co.

     114,508,992   
  1,347,100      

United Continental Holdings, Inc. (a)

     80,475,754   
  86,000      

United Parcel Service, Inc. – Class B

     8,645,580   
     

 

 

 
        555,781,587   
     

 

 

 
Information Technology – 28.4%  
  1,533,400      

Adobe Systems, Inc. (a)

     116,630,404   
  312,900      

Alibaba Group Holding Ltd. – ADR (a)

     25,435,641   
  1,115,170      

Altera Corp.

     46,480,286   
  137,000      

Analog Devices, Inc.

     8,472,080   
  51,700      

Applied Materials, Inc.

     1,023,143   
  272,517      

ASML Holding N.V.

     29,170,220   
  9,028,550      

BlackBerry Ltd. (a)

     91,730,068   
  203,612      

Broadcom Corp. – Class A

     9,000,668   
  704,000      

Cisco Systems, Inc.

     20,296,320   
  350,000      

Corning, Inc.

     7,325,500   
  1,320,100      

Cree, Inc. (a)

     41,820,768   
  34,300      

eBay, Inc. (a)

     1,998,318   
  275,000      

Electronic Arts, Inc. (a)

     15,974,750   
  767,000      

Ellie Mae, Inc. (a)

     42,185,000   
  1,629,700      

EMC Corp.

     43,855,227   
  115,500      

F5 Networks, Inc. (a)

     14,093,310   
  4,308,700      

Flextronics International Ltd. (a)

     49,657,767   
  658,418      

FormFactor, Inc. (a)

     5,247,591   
  114,567      

Google, Inc. – Class A (a)

     62,870,933   
  115,283      

Google, Inc. – Class C (a)

     61,945,975   

 

The accompanying notes are an integral part of these financial statements.

 

19


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Information Technology (continued)  
  1,589,300      

Hewlett-Packard Co.

   $ 52,399,221   
  1,496,400      

Intel Corp.

     48,707,820   
  105,000      

Intuit, Inc.

     10,534,650   
  420,000      

Jabil Circuit, Inc.

     9,458,400   
  758,150      

Keysight Technologies, Inc. (a)

     25,367,699   
  420,000      

KLA-Tencor Corp.

     24,696,000   
  5,765,700      

L.M. Ericsson Telephone Co. – ADR

     62,961,444   
  725,000      

Micron Technology, Inc. (a)

     20,394,250   
  2,427,100      

Microsoft Corp.

     118,054,144   
  2,529,011      

NetApp, Inc.

     91,676,649   
  1,653,100      

NeuStar, Inc. – Class A (a)

     49,593,000   
  2,030,000      

Nuance Communications, Inc. (a)

     31,119,900   
  678,000      

NVIDIA Corp.

     15,048,210   
  843,250      

QUALCOMM, Inc.

     57,341,000   
  160,000      

Rambus, Inc. (a)

     2,214,400   
  1,073,800      

SanDisk Corp.

     71,880,172   
  275,000      

Stratasys Ltd. (a)

     10,298,750   
  185,000      

Symantec Corp.

     4,611,125   
  1,793,895      

Texas Instruments, Inc.

     97,247,048   
  933,700      

Trimble Navigation Ltd. (a)

     23,743,991   
  1,120,000      

Visa, Inc. – Class A

     73,976,000   
  270,100      

VMware, Inc. – Class A (a)

     23,795,810   
     

 

 

 
        1,620,333,652   
     

 

 

 
Materials – 1.0%  
  394,500      

Monsanto Co.

     44,957,220   
  100,000      

Praxair, Inc.

     12,193,000   
     

 

 

 
        57,150,220   
     

 

 

 

 
 

TOTAL COMMON STOCKS
(Cost $3,466,020,945)

   $ 5,252,726,530   
     

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

20


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
  SHORT-TERM INVESTMENTS – 8.2%   
  465,687,294      

Dreyfus Treasury Prime Cash Management Fund

   $ 465,687,294   
     

 

 

 

 
 

TOTAL SHORT-TERM INVESTMENTS
(Cost $465,687,294)

     465,687,294   
     

 

 

 

 
 

TOTAL INVESTMENTS
(Cost $3,931,708,239) – 100.1%

     5,718,413,824   

 

Liabilities in Excess of Other Assets – (0.1)%

     (3,209,335 ) 
     

 

 

 

 

TOTAL NET ASSETS – 100.0%

   $ 5,715,204,489   
     

 

 

 

 

ADR  American Depository Receipt

CHF  Swiss Francs

EUR  Euros

(a) Non-Income Producing
(b) Considered an affiliated company of the fund as the fund owns 5% or more of the outstanding voting securities of such company.

The Global Industry Classification Standard (GICS®) was developed by and is the exclusive property of MSCI Inc. and Standard & Poor's Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by the fund's administrator.

 

The accompanying notes are an integral part of these financial statements.

 

21


Table of Contents
LOGO  

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

April 30, 2015 (Unaudited)

 

Shares            Value  
  COMMON STOCKS – 99.0%   
Consumer Discretionary – 15.7%       
  2,248,000      

Ascena Retail Group, Inc. (a)

   $ 33,697,520   
  13,500      

Boot Barn Holdings, Inc. (a)

     335,070   
  1,283,400      

CarMax, Inc. (a)

     87,412,374   
  4,798,800      

Chegg, Inc. (a) (b)

     35,655,084   
  74,700      

DIRECTV (a)

     6,775,663   
  5,706,700      

DreamWorks Animation SKG, Inc. – Class A (a) (b)

     148,716,602   
  496,400      

Gildan Activewear, Inc.

     15,740,844   
  300,000      

Norwegian Cruise Line Holdings Ltd. (a)

     14,553,000   
  5,460,000      

Quiksilver, Inc. (a)

     9,063,600   
  1,077,201      

Royal Caribbean Cruises Ltd.

     73,314,300   
  3,056,100      

Shutterfly, Inc. (a) (b)

     136,791,036   
  7,399,000      

Sony Corp. – ADR

     223,671,770   
  263,790      

Tesla Motors, Inc. (a)

     59,629,730   
  1,799,500      

Tribune Media Co. – Class A

     100,897,965   
  1,566,151      

Tribune Publishing Co. (b)

     27,517,273   
  4,369,500      

Tuesday Morning Corp. (a) (b)

     69,125,490   
  608,900      

Urban Outfitters, Inc. (a)

     24,380,356   
     

 

 

 
        1,067,277,677   
     

 

 

 
Consumer Staples – 0.5%       
  3,424,968      

Boulder Brands, Inc. (a) (b)

     32,674,195   
  12,000      

Post Holdings, Inc. (a)

     563,280   
     

 

 

 
        33,237,475   
     

 

 

 
Energy – 1.4%       
  520,400      

Cabot Oil & Gas Corp.

     17,599,928   
  5,400      

Cameron International Corp. (a)

     296,028   
  50,000      

EOG Resources, Inc.

     4,947,500   
  85,800      

National Oilwell Varco, Inc.

     4,668,378   
  37,000      

Range Resources Corp.

     2,351,720   
  1,790,000      

Rex Energy Corp. (a)

     8,950,000   
  7,432,813      

Solazyme, Inc. (a) (b)

     28,616,330   
  1,428,682      

Transocean Ltd.

     26,887,795   
     

 

 

 
        94,317,679   
     

 

 

 
Financials – 2.4%       
  680,000      

CME Group, Inc.

     61,818,800   
  127,500      

Discover Financial Services

     7,391,175   
  489,700      

E*TRADE Financial Corp. (a)

     14,098,463   

 

The accompanying notes are an integral part of these financial statements.

 

22


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Financials (continued)       
  905,820      

MarketAxess Holdings, Inc.

   $ 77,764,647   
  30,000      

Progressive Corp. (The)

     799,800   
     

 

 

 
        161,872,885   
     

 

 

 
Health Care – 32.8%       
  1,839,251      

Abaxis, Inc. (b)

     117,712,064   
  1,503,300      

Abbott Laboratories

     69,783,186   
  2,637,173      

ABIOMED, Inc. (a) (b)

     166,722,077   
  3,666,900      

Accuray, Inc. (a)

     29,811,897   
  5,007,000      

Affymetrix, Inc. (a) (b)

     60,734,910   
  6,800      

Avalanche Biotechnologies, Inc. (a)

     216,648   
  204,100      

Biogen, Inc. (a)

     76,319,113   
  602,300      

BioMarin Pharmaceutical, Inc. (a)

     67,487,715   
  99,000      

Boston Scientific Corp. (a)

     1,764,180   
  5,315,500      

Cardica, Inc. (a) (b)

     2,168,724   
  999,700      

Cepheid, Inc. (a)

     56,083,170   
  7,400,000      

Cerus Corp. (a) (b)

     32,856,000   
  592,000      

Charles River Laboratories International, Inc. (a)

     40,942,720   
  7,744,720      

Dyax Corp. (a) (b)

     185,176,255   
  1,100,000      

Eli Lilly & Co.

     79,057,000   
  3,439,862      

Epizyme, Inc. (a) (b)

     56,104,149   
  2,035,000      

Exact Sciences Corp. (a)

     42,531,500   
  103,800      

Flex Pharma, Inc. (a)

     1,735,536   
  2,797,732      

Fluidigm Corp. (a) (b)

     104,803,041   
  113,000      

Illumina, Inc. (a)

     20,820,250   
  3,769,817      

ImmunoGen, Inc. (a)

     31,176,387   
  1,832,745      

Insulet Corp. (a)

     54,707,438   
  1,352,200      

KaloBios Pharmaceuticals, Inc. (a)

     673,937   
  1,778,283      

Momenta Pharmaceuticals, Inc. (a)

     31,031,038   
  11,643,830      

Nektar Therapeutics (a) (b)

     110,849,262   
  1,224,082      

Novadaq Technologies, Inc. (a)

     13,232,326   
  505,000      

NuVasive, Inc. (a)

     22,588,650   
  144,100      

OncoMed Pharmaceuticals, Inc. (a)

     3,455,518   
  1,523,900      

OraSure Technologies, Inc. (a)

     9,600,570   
  2,205,000      

Pfenex, Inc. (a) (b)

     29,436,750   
  1,197,939      

Pharmacyclics, Inc. (a)

     306,911,972   
  5,501,614      

QIAGEN N.V. (a)

     130,993,429   
  426,400      

Roche Holding AG – CHF

     123,127,885   
  3,270,900      

Seattle Genetics, Inc. (a)

     112,322,706   
  1,132,000      

Tekmira Pharmaceuticals Corp. (a)

     17,512,040   

 

The accompanying notes are an integral part of these financial statements.

 

23


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Health Care (continued)       
  1,714,100      

Xencor, Inc. (a)

   $ 24,374,502   
  74,000      

XenoPort, Inc. (a)

     438,820   
     

 

 

 
        2,235,263,365   
     

 

 

 
Industrials – 16.6%       
  390,000      

AECOM (a)

     12,308,400   
  772,400      

Alaska Air Group, Inc.

     49,479,944   
  3,500      

Allegiant Travel Co.

     538,160   
  3,241,700      

American Airlines Group, Inc.

     156,525,485   
  125,000      

C.H. Robinson Worldwide, Inc.

     8,048,750   
  199,500      

CIRCOR International, Inc.

     10,900,680   
  16,000      

Controladora Comercial Mexicana, S.A. de C.V. – ADR (a)

     198,720   
  171,400      

Curtiss-Wright Corp.

     12,522,484   
  3,310,900      

Delta Air Lines, Inc.

     147,798,576   
  42,800      

Esterline Technologies Corp. (a)

     4,763,212   
  600,000      

Hawaiian Holdings, Inc. (a)

     13,848,000   
  604,500      

Hertz Global Holdings, Inc. (a)

     12,597,780   
  947,600      

Jacobs Engineering Group, Inc. (a)

     40,614,136   
  6,630,925      

JetBlue Airways Corp. (a)

     136,132,890   
  435,000      

NCI Building Systems, Inc. (a)

     6,733,800   
  552,000      

NN, Inc.

     13,888,320   
  3,474,100      

Polypore International, Inc. (a) (b)

     203,443,296   
  575,372      

Ritchie Bros. Auctioneers, Inc.

     14,551,158   
  907,000      

Southwest Airlines Co.

     36,787,920   
  470,500      

Spirit Airlines, Inc. (a)

     32,215,135   
  2,400      

TransDigm Group, Inc. (a)

     509,112   
  148,137      

Trex Co., Inc. (a)

     6,950,588   
  3,212,600      

United Continental Holdings, Inc. (a)

     191,920,724   
  2,141,000      

UTi Worldwide, Inc.

     19,333,230   
     

 

 

 
        1,132,610,500   
     

 

 

 
Information Technology – 27.8%       
  90,000      

A10 Networks, Inc. (a)

     409,500   
  1,062,100      

Adobe Systems, Inc. (a)

     80,783,326   
  893,700      

Altera Corp.

     37,249,416   
  15,000      

Applied Materials, Inc.

     296,850   
  14,700      

Arista Networks, Inc. (a)

     940,947   
  150,000      

ASML Holding N.V.

     16,056,000   
  2,251,023      

Audience, Inc. (a) (b)

     10,714,869   
  11,200,000      

Axcelis Technologies, Inc. (a) (b)

     28,224,000   
  18,497,218      

BlackBerry Ltd. (a)

     187,931,735   

 

The accompanying notes are an integral part of these financial statements.

 

24


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Information Technology (continued)       
  20,000      

Broadcom Corp. – Class A

   $ 884,100   
  3,455,360      

comScore, Inc. (a) (b)

     180,922,650   
  817,500      

Cray, Inc. (a)

     22,963,575   
  1,675,300      

Cree, Inc. (a)

     53,073,504   
  16,900      

eBay, Inc. (a)

     984,594   
  150,000      

Electronic Arts, Inc. (a)

     8,713,500   
  2,790,800      

Ellie Mae, Inc. (a) (b)

     153,494,000   
  1,780,000      

EMC Corp.

     47,899,800   
  624,200      

F5 Networks, Inc. (a)

     76,164,884   
  1,395,222      

FARO Technologies, Inc. (a) (b)

     55,571,692   
  377,000      

FEI Co.

     28,448,420   
  300      

FireEye, Inc. (a)

     12,390   
  7,626,900      

Flextronics International Ltd. (a)

     87,900,022   
  1,126,300      

FormFactor, Inc. (a)

     8,976,611   
  103,370      

Google, Inc. – Class A (a)

     56,726,355   
  103,654      

Google, Inc. – Class C (a)

     55,697,334   
  2,867,515      

Guidance Software, Inc. (a) (b)

     16,746,288   
  119,000      

Hewlett-Packard Co.

     3,923,430   
  243,700      

Intuit, Inc.

     24,450,421   
  700,000      

Jabil Circuit, Inc.

     15,764,000   
  77,000      

Keysight Technologies, Inc. (a)

     2,576,420   
  594,400      

KLA-Tencor Corp.

     34,950,720   
  4,451,500      

Micron Technology, Inc. (a)

     125,220,695   
  46,419      

Mobileye N.V. (a)

     2,082,356   
  1,836,367      

NetApp, Inc.

     66,568,304   
  1,414,086      

NeuStar, Inc. – Class A (a)

     42,422,580   
  202,000      

Nimble Storage, Inc. (a)

     4,940,920   
  2,972,406      

Nuance Communications, Inc. (a)

     45,566,984   
  2,697,455      

NVIDIA Corp.

     59,870,014   
  701,300      

QUALCOMM, Inc.

     47,688,400   
  137,200      

Rambus, Inc. (a)

     1,898,848   
  1,073,300      

SanDisk Corp.

     71,846,702   
  8,453,200      

ServiceSource International, Inc. (a) (b)

     30,177,924   
  200,000      

SMART Technologies, Inc. – Class A (a)

     232,000   
  310,000      

Stratasys Ltd. (a)

     11,609,500   
  728,000      

Trimble Navigation Ltd. (a)

     18,513,040   
  4,400      

Twitter, Inc. (a)

     171,424   
  455,000      

Universal Display Corp. (a)

     20,051,850   

 

The accompanying notes are an integral part of these financial statements.

 

25


Table of Contents

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

 

April 30, 2015 (Unaudited) – continued

 

Shares            Value  
Information Technology (continued)       
  200,000      

VMware, Inc. – Class A (a)

   $ 17,620,000   
  1,462,000      

Xoom Corp. (a)

     25,833,540   
     

 

 

 
        1,891,766,434   
     

 

 

 
Materials – 0.6%       
  2,325,000      

Marrone Bio Innovations, Inc. (a) (b)

     7,765,500   
  284,300      

Monsanto Co.

     32,398,828   
  94,100      

Potash Corp. of Saskatchewan, Inc.

     3,071,424   
     

 

 

 
        43,235,752   
     

 

 

 
Telecommunication Services – 1.2%       
  15,520,000      

Sprint Corp. (a)

     79,617,600   
     

 

 

 

 
 

TOTAL COMMON STOCKS
(Cost $4,331,339,275)

   $ 6,739,199,367   
     

 

 

 
SHORT-TERM INVESTMENTS – 1.1%       
  73,582,959      

Dreyfus Treasury Prime Cash Management Fund

     73,582,959   
     

 

 

 

 
 

TOTAL SHORT-TERM INVESTMENTS
(Cost $73,582,959)

     73,582,959   
     

 

 

 

 
 

TOTAL INVESTMENTS
(Cost $4,404,922,234) – 100.1%

     6,812,782,326   

 

Liabilities in Excess of Other Assets – (0.1)%

     (9,452,785 ) 
     

 

 

 

 

TOTAL NET ASSETS – 100.0%

   $ 6,803,329,541   
     

 

 

 

 

ADR  American Depository Receipt

CHF  Swiss Francs

(a) Non-Income Producing
(b) Considered an affiliated company of the fund as the fund owns 5% or more of the outstanding voting securities of such company.

The Global Industry Classification Standard (GICS®) was developed by and is the exclusive property of MSCI Inc. and Standard & Poor's Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by the fund's administrator.

 

The accompanying notes are an integral part of these financial statements.

 

26


Table of Contents
LOGO  

Statements of Assets and Liabilities

PRIMECAP Odyssey Funds

April 30, 2015 (Unaudited)

 

    PRIMECAP
Odyssey
Stock Fund
    PRIMECAP
Odyssey
Growth Fund
    PRIMECAP
Odyssey Aggressive
Growth Fund
 

ASSETS

     

Investments, at cost

  $ 3,321,285,537      $ 3,931,708,239      $ 4,404,922,234   
 

 

 

   

 

 

   

 

 

 

Foreign currency, at cost

  $ 77,478      $ —      $ —   
 

 

 

   

 

 

   

 

 

 

Investments, at value (unaffiliated)

  $ 4,370,288,281      $ 5,664,238,261      $ 4,780,062,865   

Investments, at value (affiliated)

    31,917,662        54,175,563        2,032,719,461   

Foreign currency, at value

    79,279        —        —   

Cash

    —        203,424        1,721,817   

Receivable for investment sold

    5,407,423        16,106,307        2,337,807   

Receivable for dividends and interest

    5,780,447        5,994,332        4,002,703   

Receivable for fund shares sold

    10,826,700        9,346,135        6,459,202   

Prepaid expenses

    64,319        51,832        48,222   
 

 

 

   

 

 

   

 

 

 

Total assets

    4,424,364,111        5,750,115,854        6,827,352,077   
 

 

 

   

 

 

   

 

 

 
LIABILITIES      

Payable for investments purchased

    14,907,814        23,575,084        8,959,543   

Payable for fund shares repurchased

    1,679,007        3,235,471        5,272,360   

Payable to the advisor (Note 6)

    5,665,387        7,354,603        9,123,638   

Other accrued expenses and liabilities

    640,537        746,207        666,995   
 

 

 

   

 

 

   

 

 

 

Total liabilities

    22,892,745        34,911,365        24,022,536   
 

 

 

   

 

 

   

 

 

 

NET ASSETS

  $ 4,401,471,366      $ 5,715,204,489      $ 6,803,329,541   
 

 

 

   

 

 

   

 

 

 

Number of shares issued and outstanding (unlimited shares authorized, $0.01 par value)

    181,286,372        214,645,007        196,922,954   
 

 

 

   

 

 

   

 

 

 

NET ASSET VALUE, OFFERING AND REDEMPTION PRICE PER SHARE

  $ 24.28      $ 26.63      $ 34.55   
 

 

 

   

 

 

   

 

 

 
COMPONENTS OF NET ASSETS      

Paid-in capital

  $ 3,272,679,855      $ 3,878,886,692      $ 4,351,198,578   

Undistributed net investment income

    18,857,370        13,462,176        8,751,104   

Accumulated net realized gain

    29,019,231        36,168,046        35,531,606   

Net unrealized appreciation

    1,080,914,910        1,786,687,575        2,407,848,253   
 

 

 

   

 

 

   

 

 

 

Net assets

  $ 4,401,471,366      $ 5,715,204,489      $ 6,803,329,541   
 

 

 

   

 

 

   

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

27


Table of Contents
LOGO  

Statements of Operations

PRIMECAP Odyssey Funds

For the Six Months Ended April 30, 2015 (Unaudited)

 

    PRIMECAP
Odyssey
Stock Fund
    PRIMECAP
Odyssey

Growth  Fund
    PRIMECAP
Odyssey Aggressive
Growth Fund
 

INVESTMENT INCOME

     

Income

     

Dividends (1)(2)

  $ 50,562,607      $ 40,384,161      $ 39,208,180   

Interest

    273        60        28   
 

 

 

   

 

 

   

 

 

 

Total income

    50,562,880        40,384,221        39,208,208   
 

 

 

   

 

 

   

 

 

 

Expenses

     

Advisory fees

    10,876,172        14,204,321        17,772,551   

Shareholder servicing

    1,251,509        1,241,099        1,091,220   

Custody

    116,943        142,656        145,091   

Trustee fees

    32,629        32,654        32,624   

Other

    655,597        713,941        809,850   
 

 

 

   

 

 

   

 

 

 

Total expenses

    12,932,850        16,334,671        19,851,336   
 

 

 

   

 

 

   

 

 

 

Net investment income

    37,630,030        24,049,550        19,356,872   
 

 

 

   

 

 

   

 

 

 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY      

Net realized gain (loss) on:

     

Investments (3)

    32,966,787        40,645,483        44,469,458   

Foreign currency transactions

    (86,042 )      (115,863 )      (84,235 ) 

Change in unrealized appreciation/depreciation on:

     

Investments

    148,124,847        176,023,638        491,290,810   

Foreign currency translations

    73,912        113,376        79,472   
 

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain on investments and foreign currency

    181,079,504        216,666,634        535,755,505   
 

 

 

   

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 218,709,534      $ 240,716,184      $ 555,112,377   
 

 

 

   

 

 

   

 

 

 

 

  (1) 

Net of foreign taxes withheld of $1,218,463, $1,305,935, and $592,490, respectively.

  (2) 

Includes dividend income from affiliates of $624,523, $0, and $908,609, respectively.

  (3) 

Includes net realized gains on sales of affiliated companies of $0, $0, and $10,952,603, respectively.

 

The accompanying notes are an integral part of these financial statements.

 

28


Table of Contents
LOGO  

Statements of Changes in Net Assets

PRIMECAP Odyssey Stock Fund

 

    Six Months
Ended
April 30, 2015(1)
    Year Ended
October 31, 2014
 

INCREASE (DECREASE) IN NET ASSETS FROM:

   
OPERATIONS    

Net investment income

  $ 37,630,030      $ 35,275,392   

Net realized gain (loss) on:

   

Investments

    32,966,787        60,873,459   

Foreign currency transactions

    (86,042 )      18,456   

Change in unrealized appreciation/depreciation on:

   

Investments

    148,124,847        312,188,980   

Foreign currency translations

    73,912        (109,276 ) 
 

 

 

   

 

 

 

Net increase in net assets resulting from operations

    218,709,534        408,247,011   
 

 

 

   

 

 

 
DISTRIBUTIONS TO SHAREHOLDERS FROM:    

Net investment income

    (48,367,226 )      (25,544,000 ) 

Net realized gain on investments

    (55,247,855 )      (7,013,392 ) 
 

 

 

   

 

 

 

Net decrease in net assets resulting from distributions paid

    (103,615,081 )      (32,557,392 ) 
 

 

 

   

 

 

 
CAPITAL SHARE TRANSACTIONS    

Proceeds from shares sold

    982,335,909        1,379,398,107   

Proceeds from reinvestment of distributions

    64,917,038        19,473,550   

Cost of shares repurchased

    (293,396,003 )      (376,708,561 ) 
 

 

 

   

 

 

 

Net increase from capital share transactions

    753,856,944        1,022,163,096   
 

 

 

   

 

 

 

Total increase in net assets

    868,951,397        1,397,852,715   
NET ASSETS    

Beginning of period

    3,532,519,969        2,134,667,254   
 

 

 

   

 

 

 

End of period (includes undistributed net investment
income of $18,857,370 and $29,594,566, respectively)

  $ 4,401,471,366      $ 3,532,519,969   
 

 

 

   

 

 

 
CHANGE IN CAPITAL SHARES    

Shares outstanding, beginning of period

    149,772,161        103,820,982   
 

 

 

   

 

 

 

Shares sold

    40,943,542        62,248,954   

Shares issued on reinvestment of distributions

    2,822,480        943,029   

Shares repurchased

    (12,251,811 )      (17,240,804 ) 
 

 

 

   

 

 

 

Net increase in capital shares

    31,514,211        45,951,179   
 

 

 

   

 

 

 

Shares outstanding, end of period

    181,286,372        149,772,161   
 

 

 

   

 

 

 

 

  (1) 

Unaudited

 

The accompanying notes are an integral part of these financial statements.

 

29


Table of Contents
LOGO  

Statements of Changes in Net Assets

PRIMECAP Odyssey Growth Fund

 

    Six Months
Ended
April 30, 2015(1)
    Year Ended
October 31, 2014
 

INCREASE (DECREASE) IN NET ASSETS FROM:

   
OPERATIONS    

Net investment income

  $ 24,049,550      $ 22,842,718   

Net realized gain (loss) on:

   

Investments

    40,645,483        128,037,118   

Foreign currency transactions

    (115,863 )      28,407   

Change in unrealized appreciation/depreciation on:

   

Investments

    176,023,638        457,447,081   

Foreign currency translations

    113,376        (180,298 ) 
 

 

 

   

 

 

 

Net increase in net assets resulting from operations

    240,716,184        608,175,026   
 

 

 

   

 

 

 
DISTRIBUTIONS TO SHAREHOLDERS FROM:    

Net investment income

    (30,191,725 )      (12,772,829 ) 

Net realized gain on investments

    (118,727,114 )      (73,025,511 ) 
 

 

 

   

 

 

 

Net decrease in net assets resulting from distributions paid

    (148,918,839 )      (85,798,340 ) 
 

 

 

   

 

 

 
CAPITAL SHARE TRANSACTIONS    

Proceeds from shares sold

    1,224,422,600        1,300,616,020   

Proceeds from reinvestment of distributions

    139,731,442        81,199,742   

Cost of shares repurchased

    (436,957,269 )      (869,158,941 ) 
 

 

 

   

 

 

 

Net increase from capital share transactions

    927,196,773        512,656,821   
 

 

 

   

 

 

 

Total increase in net assets

    1,018,994,118        1,035,033,507   
NET ASSETS    

Beginning of period

    4,696,210,371        3,661,176,864   
 

 

 

   

 

 

 

End of period (includes undistributed net investment
income of $13,462,176 and $19,604,351, respectively)

  $ 5,715,204,489      $ 4,696,210,371   
 

 

 

   

 

 

 
CHANGE IN CAPITAL SHARES    

Shares outstanding, beginning of period

    179,647,788        158,564,375   
 

 

 

   

 

 

 

Shares sold

    45,994,396        53,188,883   

Shares issued on reinvestment of distributions

    5,542,699        3,512,100   

Shares repurchased

    (16,539,876 )      (35,617,570 ) 
 

 

 

   

 

 

 

Net increase in capital shares

    34,997,219        21,083,413   
 

 

 

   

 

 

 

Shares outstanding, end of period

    214,645,007        179,647,788   
 

 

 

   

 

 

 

 

  (1) 

Unaudited

 

The accompanying notes are an integral part of these financial statements.

 

30


Table of Contents
LOGO  

Statements of Changes in Net Assets

PRIMECAP Odyssey Aggressive Growth Fund

 

    Six Months
Ended
April 30, 2015(1)
    Year Ended
October 31, 2014
 

INCREASE (DECREASE) IN NET ASSETS FROM:

   
OPERATIONS    

Net investment income (loss)

  $ 19,356,872      $ (4,723,431 ) 

Net realized gain (loss) on:

   

Investments

    44,469,458        286,679,248   

Foreign currency transactions

    (84,235 )      20,598   

Change in unrealized appreciation/depreciation on:

   

Investments

    491,290,810        566,323,190   

Foreign currency translations

    79,472        (125,377 ) 
 

 

 

   

 

 

 

Net increase in net assets resulting from operations

    555,112,377        848,174,228   
 

 

 

   

 

 

 
DISTRIBUTIONS TO SHAREHOLDERS FROM:    

Net investment income

    (10,605,768 )      –   

Net realized gain on investments

    (273,260,143 )      (82,866,081 ) 
 

 

 

   

 

 

 

Net decrease in net assets resulting from distributions paid

    (283,865,911 )      (82,866,081 ) 
 

 

 

   

 

 

 
CAPITAL SHARE TRANSACTIONS    

Proceeds from shares sold

    790,304,064        1,984,230,161   

Proceeds from reinvestment of distributions

    266,806,818        78,132,373   

Cost of shares repurchased

    (487,559,298 )      (1,308,262,342 ) 
 

 

 

   

 

 

 

Net increase from capital share transactions

    569,551,584        754,100,192   
 

 

 

   

 

 

 

Total increase in net assets

    840,798,050        1,519,408,339   
NET ASSETS    

Beginning of period

    5,962,531,491        4,443,123,152   
 

 

 

   

 

 

 

End of period (includes undistributed net investment
income of $8,751,104 and $0, respectively)

  $ 6,803,329,541      $ 5,962,531,491   
 

 

 

   

 

 

 
CHANGE IN CAPITAL SHARES    

Shares outstanding, beginning of period

    179,545,427        154,739,429   
 

 

 

   

 

 

 

Shares sold

    23,279,667        65,025,913   

Shares issued on reinvestment of distributions

    8,581,757        2,702,289   

Shares repurchased

    (14,483,897 )      (42,922,204 ) 
 

 

 

   

 

 

 

Net increase in capital shares

    17,377,527        24,805,998   
 

 

 

   

 

 

 

Shares outstanding, end of period

    196,922,954        179,545,427   
 

 

 

   

 

 

 

 

  (1) 

Unaudited

 

The accompanying notes are an integral part of these financial statements.

 

31


Table of Contents
LOGO  

Financial Highlights

PRIMECAP Odyssey Stock Fund

For a capital share outstanding throughout each period.

 

    Six Months
Ended

Apr. 30,
2015(1)
    Year
Ended
Oct. 31,
2014
    Year
Ended
Oct. 31,
2013
    Year
Ended
Oct. 31,
2012
    Year
Ended
Oct. 31,
2011
    Year
Ended
Oct. 31,
2010
 

Net asset value, beginning of the period

  $ 23.59      $ 20.56      $ 15.75      $ 14.32      $ 13.48      $ 11.69   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from investment operations:

           

Net investment income

    0.22        0.25        0.27        0.21        0.16        0.09 (4) 

Net realized and unrealized gain on investments and foreign currency

    1.13        3.09        4.79        1.40        0.79        1.79   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

    1.35        3.34        5.06        1.61        0.95        1.88   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less:

           

Dividends from net investment income

    (0.31 )      (0.24 )      (0.25 )      (0.18 )      (0.11 )      (0.09 ) 

Distributions from net realized gain

    (0.35 )      (0.07 )      —        —        —        —   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.66 )      (0.31 )      (0.25 )      (0.18 )      (0.11 )      (0.09 ) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 24.28      $ 23.59      $ 20.56      $ 15.75      $ 14.32      $ 13.48   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total return

    5.90 %(3)      16.45 %      32.55 %      11.39 %      7.05 %      16.14 % 

Ratios/supplemental data:

           

Net assets, end of period (millions)

  $ 4,401.5      $ 3,532.5      $ 2,134.7      $ 1,522.2      $ 904.3      $ 607.1   

Ratio of expenses to average net assets

    0.66 %(2)      0.62 %      0.63 %      0.66 %      0.66 %      0.71 % 

Ratio of net investment income to average net assets

    1.91 %(2)      1.34 %      1.65 %      1.57 %      1.25 %      1.37 %(4) 

Portfolio turnover rate

    5 %(3)      8 %      15 %      11 %      24 %      3 % 

 

  (1) 

Unaudited

  (2) 

Annualized

  (3) 

Not annualized

  (4) 

Investment income per share reflects a special dividend of $0.05. Excluding the special dividend, the ratio of net investment income to average net assets would have been 0.74%.

 

The accompanying notes are an integral part of these financial statements.

 

32


Table of Contents
LOGO  

Financial Highlights

PRIMECAP Odyssey Growth Fund

For a capital share outstanding throughout each period.

 

    Six Months
Ended

Apr.  30,
2015(1)
    Year
Ended
Oct. 31,
2014
    Year
Ended
Oct. 31,
2013
    Year
Ended
Oct. 31,
2012
    Year
Ended
Oct. 31,
2011
    Year
Ended
Oct. 31,
2010
 

Net asset value, beginning of the period

  $ 26.14      $ 23.09      $ 16.83      $ 15.44      $ 14.70      $ 12.18   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from investment operations:

           

Net investment income

    0.12        0.13        0.10        0.09        0.04        0.02   

Net realized and unrealized gain on investments and foreign currency

    1.18        3.45        6.26        1.42        0.71        2.53   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

    1.30        3.58        6.36        1.51        0.75        2.55   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less:

           

Dividend from investment income

    (0.16 )      (0.08 )      (0.10 )      (0.06 )      (0.01 )      (0.03 ) 

Distributions from net realized gain

    (0.65 )      (0.45 )      —        (0.06 )      —        —   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.81 )      (0.53 )      (0.10 )      (0.12 )      (0.01 )      (0.03 ) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 26.63      $ 26.14      $ 23.09      $ 16.83      $ 15.44      $ 14.70   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total return

    5.14 %(3)      15.82 %      38.02 %      9.86 %      5.13 %      20.96 % 

Ratios/supplemental data:

           

Net assets, end of period (millions)

  $ 5,715.2      $ 4,696.2      $ 3,661.2      $ 2,201.9      $ 1,821.9      $ 1,451.2   

Ratio of expenses to average net assets

    0.63 %(2)      0.63 %      0.65 %      0.67 %      0.66 %      0.68 % 

Ratio of net investment income to average net assets

    0.93 %(2)      0.54 %      0.51 %      0.55 %      0.26 %      0.15 % 

Portfolio turnover rate

    4 %(3)      10 %      10 %      12 %      13 %      5 % 

 

  (1) 

Unaudited

  (2) 

Annualized

  (3) 

Not annualized

 

The accompanying notes are an integral part of these financial statements.

 

33


Table of Contents
LOGO  

Financial Highlights

PRIMECAP Odyssey Aggressive Growth Fund

For a capital share outstanding throughout each period.

 

    Six Months
Ended

Apr.  30,
2015(1)
    Year
Ended
Oct. 31,
2014
    Year
Ended
Oct. 31,
2013
    Year
Ended
Oct. 31,
2012
    Year
Ended
Oct. 31,
2011
    Year
Ended
Oct. 31,
2010
 

Net asset value, beginning of the period

  $ 33.21      $ 28.71      $ 18.86      $ 16.99      $ 16.17      $ 12.33   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from investment operations:

           

Net investment income (loss)

    0.10        (0.03 )      (0.04 )      (0.05 )      (0.05 )      (0.05 ) 

Net realized and unrealized gain on investments and foreign currency

    2.78        5.04        9.89        2.24        1.40        3.89   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

    2.88        5.01        9.85        2.19        1.35        3.84   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less:

           

Dividend from investment income

    (0.06 )      —        —        —        —        —   

Distributions from net realized gain

    (1.48 )      (0.51 )      —        (0.32 )      (0.53 )      —   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (1.54 )      (0.51 )      —        (0.32 )      (0.53 )      —   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 34.55      $ 33.21      $ 28.71      $ 18.86      $ 16.99      $ 16.17   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total return

    9.18 %(3)      17.71 %      52.23 %      13.25 %      8.50 %      31.14 % 

Ratios/supplemental data:

           

Net assets, end of period (millions)

  $ 6,803.3      $ 5,962.5      $ 4,443.1      $ 1,541.5      $ 1,134.5      $ 809.9   

Ratio of expenses to average net assets

    0.62 %(2)      0.62 %      0.64 %      0.68 %      0.68 %      0.71 % 

Ratio of net investment income (loss) to average net assets

    0.60 %(2)      (0.09 %)      (0.23 %)      (0.32 %)      (0.33 %)      (0.45 %) 

Portfolio turnover rate

    4 %(3)      13 %      11 %      14 %      11 %      15 % 

 

  (1) 

Unaudited

  (2) 

Annualized

  (3) 

Not annualized

 

The accompanying notes are an integral part of these financial statements.

 

34


Table of Contents
LOGO  

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Six Months Ended April 30, 2015 (Unaudited)

 

(1)  Organization

PRIMECAP Odyssey Funds (the “Trust”) was organized on June 8, 2004 as a Delaware statutory trust and is registered as an open-end management investment company under the Investment Company Act of 1940, as amended (the “1940 Act”). The Trust is comprised of three series: PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund (the “Funds”), each of which is diversified within the meaning of the 1940 Act. PRIMECAP Management Company (the “Investment Advisor”) serves as investment advisor to the Funds. Each Fund commenced operations on November 1, 2004.

Each Fund’s investment objective is to achieve long-term capital appreciation. Each Fund is authorized to issue unlimited shares of beneficial interest. All shares of each Fund have equal rights with respect to voting. The PRIMECAP Odyssey Aggressive Growth Fund is closed to most new investors.

(2)  Significant Accounting Policies

The Funds consistently follow the accounting policies set forth below which are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Funds are considered investment companies under U.S. GAAP and follow the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Auditing Standards Codification Topic 946.

 

  A. Security Valuation

Securities traded on a national securities exchange are valued at the last reported sales price at the close of regular trading on each day the exchanges are open for trading. Securities traded on the National Association of Securities Dealers Automated Quotations (“NASDAQ”) are valued at the NASDAQ Official Closing Price, which may not necessarily represent the last sale price. Non-U.S. traded stocks are valued at the last sale price or official closing price in the primary local market where the stock is traded. Securities traded on an exchange for which there have been no sales are valued at the mean between the bid and ask price. Because trading on most non-U.S. exchanges is normally completed before the close of the New York Stock Exchange, the value of securities traded on foreign exchanges can change by the time a Fund calculates its net asset value per share (“NAV”). To address these changes, the Funds may utilize adjustment factors provided by an independent pricing service to systematically value foreign securities at fair value. These adjustment factors are based on statistical analyses of subsequent movement in securities indices, specific security prices, and exchange rates in foreign markets.

Securities for which quotations are not readily available are valued at their respective fair values as determined in good faith by a valuation committee of the Investment Advisor in accordance with procedures approved by the Trust’s Board of Trustees. In determining fair value, the Funds take into account all relevant factors and available information. Consequently, the price of a security used by a Fund to calculate its NAV may differ from quoted or published prices for the same security. Fair value pricing involves

 

35


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

subjective judgments, and there is no single standard for determining a security’s fair value. As a result, different mutual funds could reasonably arrive at a different fair value for the same security. It is possible that the fair value determined for a security is materially different from the value that could be realized upon the sale of that security or from the values that other mutual funds may determine.

Investments in other funds are valued at their respective net asset values as determined by those funds, in accordance with the 1940 Act.

 

  B. Share Valuation

The NAV of a Fund is calculated by dividing the sum of the value of the securities held by the Fund, plus cash or other assets, minus all liabilities (including estimated accrued expenses), by the total number of shares outstanding of the Fund. The result is rounded to the nearest cent. The Funds’ shares will not be priced on the days on which the NYSE is closed for trading.

 

  C. Foreign Currency

Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates as of 4 p.m. Eastern time on the valuation date. Purchases and sales of investments and dividend and interest income are converted into U.S. dollars using the spot market rate of exchange prevailing on the respective dates of such translations. Realized foreign exchange gains or losses arise from 1) sales of foreign currencies; 2) currency gains or losses realized between the trade and settlement dates on securities transactions; and 3) the difference between the recorded amounts of dividends, interest, and foreign withholding taxes and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses arise from changes in foreign exchange rates on foreign denominated assets and liabilities other than investments in securities held at the end of the reporting period. Foreign securities and currency transactions may involve risks not associated with U.S. securities and currency.

 

  D. Federal Income Taxes

Each Fund has elected to be treated as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986 (the “IRC”). Each Fund intends to distribute substantially all of its taxable income and any accumulated net realized capital gains. Accordingly, no provision for Federal income taxes has been made in the financial statements.

The Funds may be subject to foreign taxes on income, gains on investments, or currency repatriation, a portion of which may be reclaimed. The Funds will accrue such taxes and reclaims as applicable based upon their current interpretations of the tax rules and regulations that exist in the markets in which they invest.

Each Fund has adopted accounting standards regarding recognition and measurement of tax positions taken or expected to be taken on a tax return. The Funds recognize interest and penalties, if any, related to unrecognized tax benefits as income tax

 

36


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

expense in the Statement of Operations. During the six months ended April 30, 2015, the Funds did not incur any interest or penalties. As of April 30, 2015, open tax years include the tax years ended October 31, 2011 through October 31, 2014. No Fund is aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.

 

  E. Allocation of Expenses

Each Fund is charged for those expenses directly attributable to it. Expenses that are not directly attributable to a Fund are allocated among the Funds by an appropriate method based on the nature of the expense.

 

  F. Security Transactions, Investment Income, and Distributions

Security transactions are accounted for on the trade date. Dividend income and distributions to shareholders are recorded on the ex-dividend date, and interest income is recognized on the accrual basis. Realized gains and losses are evaluated on the basis of identified costs. Premiums and discounts on the purchase of securities are amortized/accreted using the effective interest method. U.S. GAAP requires that permanent financial reporting and tax differences be reclassified in the capital accounts.

 

  G. Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

  H. Indemnification Obligations

Under the Trust’s organizational documents, its current and former officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Funds. In addition, in the normal course of business, the Funds enter into contracts that contain a variety of representations and warranties that provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. Based on experience, the Funds would expect the risk of loss to be minimal.

(3)  Investment Transactions

The cost of purchases and the proceeds from sales of securities, excluding short-term investments, for the six months ended April 30, 2015 were as follows:

 

Fund

  Purchases      Sales  

PRIMECAP Odyssey Stock Fund

  $ 943,516,798       $ 187,270,436   

PRIMECAP Odyssey Growth Fund

  $ 804,036,698       $ 186,292,747   

PRIMECAP Odyssey Aggressive Growth Fund

  $ 614,330,837       $ 230,098,166   

 

37


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

(4)  Valuation Measurements

The Funds have adopted fair valuation accounting standards which establish an authoritative definition of fair value and set forth a hierarchy for measuring fair value. These standards require additional disclosure about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion of changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as “inputs”) used to value the asset or liability. These standards state that “observable inputs” reflect the assumptions that market participants would use in valuing an asset or liability based on market data obtained from independent sources. “Unobservable inputs” reflect the Funds’ own assumptions about the inputs market participants would use to value the asset or liability.

Various inputs are used in determining the value of each Fund’s investments. These inputs are summarized in the three broad levels below:

 

  Level 1 – Unadjusted quoted prices in active markets for identical securities to which the Trust has access at the date of measurement.  

 

  Level 2 – Other significant observable inputs (including quoted prices for similar or related securities in both active and inactive markets, interest rates, foreign exchange rates, and fair value estimates for foreign securities indices).  

 

  Level 3 – Significant unobservable inputs to the extent observable inputs are unavailable (including the Funds’ own assumptions in determining fair value of investments based on the best available information).  

 

38


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

The following table provides the fair value measurements of applicable Fund assets by level within the fair value hierarchy for each Fund as of April 30, 2015. There were no transfers into or out of Level 1, Level 2, or Level 3 during the reporting period. These assets are measured on a recurring basis.

 

Fund

 

Description

  Quoted prices
in active
markets for
identical assets
(Level 1)
    Significant
other
observable
inputs
(Level 2)
    Significant
unobservable
inputs
(Level 3)
    Total  

PRIMECAP

Odyssey Stock

Fund

 

Common Stock(1)

  $ 4,044,732,031      $ —      $ —      $ 4,044,732,031   
 

Short-Term Investments

    357,473,912        —        —        357,473,912   
   

 

 

   

 

 

   

 

 

   

 

 

 
 

Total Investments in Securities

  $ 4,402,205,943      $ —      $ —      $ 4,402,205,943   
   

 

 

   

 

 

   

 

 

   

 

 

 

PRIMECAP

Odyssey Growth

Fund

 

Common Stock(1)

  $ 5,252,726,530      $ —      $ —      $ 5,252,726,530   
 

Short-Term Investments

    465,687,294        —        —        465,687,294   
   

 

 

   

 

 

   

 

 

   

 

 

 
 

Total Investments in Securities

  $ 5,718,413,824      $ —      $ —      $ 5,718,413,824   
   

 

 

   

 

 

   

 

 

   

 

 

 

PRIMECAP

Odyssey

Aggressive

Growth Fund

 

Common Stock(1)

  $ 6,739,199,367      $ —      $ —      $ 6,739,199,367   
 

Short-Term Investments

    73,582,959        —        —        73,582,959   
   

 

 

   

 

 

   

 

 

   

 

 

 
 

Total Investments in Securities

  $ 6,812,782,326      $ —      $ —      $ 6,812,782,326   
   

 

 

   

 

 

   

 

 

   

 

 

 

 

  (1) 

Refer to each Fund’s respective Schedule of Investments for the breakdown of major categories.

 

39


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

(5)  Distribution to Shareholders

Net investment income and net realized gains differ for financial statement and tax purposes due to differing treatments of deferred wash sale losses.

As of October 31, 2014, the components of capital on a tax basis were as follows:

 

    PRIMECAP
Odyssey
Stock Fund
     PRIMECAP
Odyssey
Growth Fund
     PRIMECAP
Odyssey Aggressive
Growth Fund
 

Cost of investments for tax purposes(1)

  $ 2,675,548,357       $ 3,087,600,697       $ 4,059,737,598   
 

 

 

    

 

 

    

 

 

 

Gross tax unrealized appreciation

    984,062,086         1,737,237,291         2,189,651,757   

Gross tax unrealized depreciation

    (55,206,045 )       (131,046,421 )       (282,024,790 ) 
 

 

 

    

 

 

    

 

 

 

Net tax unrealized appreciation

    928,856,041         1,606,190,870         1,907,626,967   
 

 

 

    

 

 

    

 

 

 

Undistributed ordinary income

    34,662,597         37,018,979         43,677,955   

Undistributed long-term capital gain

    50,178,420         101,310,603         229,579,575   
 

 

 

    

 

 

    

 

 

 

Total distributable earnings

    84,841,017         138,329,582         273,257,530   
 

 

 

    

 

 

    

 

 

 

Other accumulated gain (loss)

    —         —         —   
 

 

 

    

 

 

    

 

 

 

Total accumulated gain

  $ 1,013,697,058       $ 1,744,520,452       $ 2,180,884,497   
 

 

 

    

 

 

    

 

 

 

 

  (1) 

At October 31, 2014 the differences in the basis for federal income tax purposes and financial reporting purposes are due to the tax deferral of losses on wash sales.

Tax components of dividends paid during the six months ended April 30, 2015 and the fiscal year ended October 31, 2014 were as follows:

 

    April 30, 2015      October 31, 2014  
    Ordinary
Income
Distributions
     Long-Term
Capital Gain
Distributions
     Ordinary
Income
Distributions
     Long-Term
Capital Gain
Distributions
 

Stock Fund

  $ 53,436,424       $ 50,178,657       $ 25,544,000       $ 7,013,392   

Growth Fund

  $ 47,607,195       $ 101,311,644       $ 12,772,829       $ 73,025,511   

Aggressive Growth Fund

  $ 54,284,835       $ 229,581,076       $ 17,599,428       $ 65,266,653   

The Funds designated as long-term capital gain dividends, pursuant to IRC Section 852 (b) (3), the amounts necessary to reduce the earnings and profits of the Funds related to net capital gains to zero for the tax year ended October 31, 2014.

 

40


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

(6)  Investment Advisory and Other Agreements

The Trust has entered into an investment management agreement with the Investment Advisor on behalf of each Fund. For its services to the Funds, the Investment Advisor receives a fee paid quarterly at the annual rate of 0.60% of the first $100 million of each Fund’s average daily net assets and 0.55% of each Fund’s average daily net assets in excess of $100 million. For the six months ended April 30, 2015, each Fund paid the Investment Advisor at an effective annual rate of 0.55% of its respective average net assets.

The Bank of New York Mellon serves as the Funds’ custodian. U.S. Bancorp Fund Services, LLC (“USBFS”) serves as the administrator, fund accountant, and transfer agent to the Funds. Quasar Distributors, LLC, an affiliate of USBFS, serves as the Funds’ distributor.

(7)  Other Affiliates

Certain of the Funds’ investments are in companies that are considered to be affiliated companies of a Fund because the Fund owns 5% or more of the outstanding voting securities of each company. Transactions during the period in securities of these companies were as follows:

PRIMECAP Odyssey Stock Fund

 

          Current Period Transactions        

Common Stock

  Market
Value at
October 31,
2014
    Purchases
at Cost
    Proceeds
from
Securities
Sold
    Dividend
Income
    Realized
Gain (Loss)
    Market
Value at
April 30,
2015
 

Tribune Publishing Co.

  $ 33,395,026      $ 1,188,129      $ —      $ 624,523      $ —      $ 31,917,662   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 33,395,026      $ 1,188,129      $ —      $ 624,523      $ —      $ 31,917,662   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

PRIMECAP Odyssey Growth Fund

 

          Current Period Transactions        

Common Stock

  Market
Value at
October 31,
2014
    Purchases
at Cost
    Proceeds
from
Securities
Sold
    Dividend
Income
    Realized
Gain (Loss)
    Market
Value at
April 30,
2015
 

ImmunoGen, Inc.

  $ 54,218,226      $ 4,437,431      $ —      $ —      $ —      $ 54,175,563   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 54,218,226      $ 4,437,431      $ —      $ —      $ —      $ 54,175,563   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

41


Table of Contents

Notes to Financial Statements

PRIMECAP Odyssey Funds

 

For the Six Months Ended April 30, 2015 (Unaudited) – continued

 

PRIMECAP Odyssey Aggressive Growth Fund

 

          Current Period Transactions        

Common Stock

  Market
Value at
October 31,
2014
    Purchases
at Cost
    Proceeds
from
Securities
Sold
    Dividend
Income
    Realized
Gain (Loss)
    Market
Value at
April 30,
2015
 

Abaxis, Inc.

  $ 96,203,817      $ 721,802      $ —      $ 366,389      $ —      $ 117,712,064   

ABIOMED, Inc.

    86,308,953        285,845        —        —        —        166,722,077   

Affymetrix, Inc.

    43,698,500        1,446,328        —        —        —        60,734,910   

Audience, Inc.

    8,396,316        —        —        —        —        10,714,869   

Axcelis Technologies, Inc.

    23,370,472        1,069,119        —        —        —        28,224,000   

Boulder Brands, Inc.(1)

    —        4,554,744        —        —        —        32,674,195   

Cardica, Inc.

    5,095,797        130,805        —        —        —        2,168,724   

Cerus Corp(1)

    —        37,834,675        —        —        —        32,856,000   

Chegg, Inc.(1)

    —        31,305,584        —        —        —        35,655,084   

comScore, Inc.

    148,769,370        —        3,367,065        —        950,210        180,922,650   

DreamWorks Animation SKG, Inc.

    122,689,276        4,933,581        —        —        —        148,716,602   

Dyax, Corp.

    95,791,053        12,202        —        —        —        185,176,255   

Ellie Mae, Inc.

    107,110,904        —        —        —        —        153,494,000   

Epizyme, Inc.(1)

    —        46,755,652        —        —        —        56,104,149   

FARO Technologies, Inc.

    77,852,432        278,426        —        —        —        55,571,692   

Fluidigm Corp.

    81,070,428        68,206        —        —        —        104,803,041   

Guidance Software, Inc.

    13,720,619        5,273,025        —        —        —        16,746,288   

Marrone Bio Innovations, Inc.

    6,091,500        —        —        —        —        7,765,500   

Nektar Therapeutics

    158,062,773        2,413,401        —        —        —        110,849,262   

Peregrine Semiconductor Corp.(2) (3)

    40,815,048        —        40,829,428        —        10,002,393        N/A   

Pfenex, Inc.(1)

    —        34,018,311        —        —        —        29,436,750   

Polypore International, Inc.

    152,362,872        222,069        —        —        —        203,443,296   

ServiceSource International, Inc.

    31,725,864        559,403        —        —        —        30,177,924   

Shutterfly, Inc.

    97,838,822        29,616,489        —        —        —        136,791,036   

Solazyme, Inc.

    48,246,701        3,478,815        —        —        —        28,616,330   

Tribune Publishing Co.

    29,204,704        596,631        —        542,220        —        27,517,273   

Tuesday Morning Corp.

    88,818,840        284,761        —        —        —        69,125,490   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,563,245,061      $ 205,859,874      $ 44,196,493      $ 908,609      $ 10,952,603      $ 2,032,719,461   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

  (1) 

As of October 31, 2014, the company was not an affiliate.

  (2) 

No longer an affiliate as of April 30, 2015.

  (3) 

Included in “Proceeds from Securities Sold” are proceeds received when Peregrine Semiconductor Corp. was acquired in an all cash transaction.

 

(8)  Subsequent Events

The Funds have evaluated subsequent events through the issuance of the financial statements and determined that no events have occurred that require disclosure.

 

42


Table of Contents
LOGO  

Expense Example

PRIMECAP Odyssey Funds

(Unaudited)

 

As a shareholder of one or more of the Funds, you incur ongoing costs, including management fees and other Fund expenses. This expense example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

The expense example is based on an investment of $1,000 invested for a six-month period beginning November 1, 2014 through April 30, 2015.

Actual Expenses

The information in the table adjacent to the heading “Actual Performance” provides actual account values and actual expenses. You may use the information in these columns, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the column entitled “Expenses Paid during Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

The information in the table adjacent to the heading “Hypothetical Performance (5% return before expenses)” provides hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratios and an assumed rate of return of 5% per year before expenses, which are not the Funds’ actual returns. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Funds and other mutual funds. To do so, compare these 5% hypothetical examples with the 5% hypothetical examples that appear in the shareholder reports of the other mutual funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only. Therefore, the information adjacent to the heading “Hypothetical Performance (5% return before expenses)” is useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different mutual funds. In addition, if transactional costs were included, your costs would have been higher.

 

43


Table of Contents

Expense Example

PRIMECAP Odyssey Funds

 

(Unaudited) – continued

 

     Beginning
Account
Value
(11/1/14)
   

Ending
Account
Value
(4/30/15)

    Expenses Paid
During Period(1)
(11/1/14 to
4/30/15)
    Expense Ratio
During Period(1)
(11/1/14 to
4/30/15)
 

PRIMECAP Odyssey Stock Fund

  

Actual Performance

  $ 1,000.00      $ 1,059.00      $ 3.37        0.66%   

Hypothetical Performance
(5% return before expenses)

  $ 1,000.00      $ 1,021.52      $ 3.31        0.66%   

PRIMECAP Odyssey Growth Fund

  

Actual Performance

  $ 1,000.00      $ 1,051.40      $ 3.20        0.63%   

Hypothetical Performance
(5% return before expenses)

  $ 1,000.00      $ 1,021.67      $ 3.16        0.63%   

PRIMECAP Odyssey Aggressive Growth Fund

  

Actual Performance

  $ 1,000.00      $ 1,091.80      $ 3.22        0.62%   

Hypothetical Performance
(5% return before expenses)

  $ 1,000.00      $ 1,021.72      $ 3.11        0.62%   

 

  (1) 

Expenses are equal to a Fund’s annualized expense ratio as indicated, multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half-year period (181), then divided by the number of days in the fiscal year (365) to reflect the one-half year period.

 

44


Table of Contents
LOGO  

Additional Information

PRIMECAP Odyssey Funds

(Unaudited)

 

Proxy Voting Procedures

The Investment Advisor votes proxies relating to portfolio securities in accordance with procedures that have been approved by the Trust’s Board of Trustees. You may obtain a description of these procedures, free of charge, by calling toll-free 1-800-729-2307. This information is also available through the Securities and Exchange Commission’s (“SEC”) website at www.sec.gov.

Proxy Voting Record

Information regarding how the Funds voted proxies relating to the portfolio securities during the most recent 12-month period ended June 30 is available, without charge, by calling toll-free 1-800-729-2307. This information is also available through the SEC’s website at www.sec.gov.

Form N-Q Disclosure

The Funds file a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. This information is available, without charge, by calling toll-free 1-800-729-2307. The Funds’ Forms N-Q are also available on the SEC’s website at www.sec.gov. The Funds’ Forms N-Q may be reviewed and copied at the Commission’s Public Reference Room in Washington, DC, and information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330.

 

45


Table of Contents
LOGO  

Management

PRIMECAP Odyssey Funds

(Unaudited)

 

Portfolio Managers

PRIMECAP Management Company has five portfolio managers who together have more than 115 years of investment experience. The portfolio managers primarily responsible for overseeing the Funds’ investments are:

 

Name   Years of Experience  

Theo A. Kolokotrones

    45   

Joel P. Fried

    30   

Alfred W. Mordecai

    18   

M. Mohsin Ansari

    15   

James Marchetti

    10   

Each of these five individuals manages a portion of the PRIMECAP Odyssey Stock Fund, the PRIMECAP Odyssey Growth Fund, and the PRIMECAP Odyssey Aggressive Growth Fund. A portion of each Fund’s assets may be managed by individuals in the Investment Advisor’s research department.

Officers and Trustees

The Trust’s officers, who oversee the Funds’ daily operations, are appointed by the Board of Trustees. The trustees are responsible for the overall management of the Trust, including establishing the Funds’ policies and general supervision and review of their investment activities. The Statement of Additional Information includes additional information about the trustees and is available, without charge, by calling 1-800-729-2307 or at the Funds’ website at www.odysseyfunds.com.

Executive Officers. The table below sets forth certain information about each of the Trust’s executive officers.

 

Name, Address
(Year of  Birth)
  Position(s)
Held
with Trust
  Term of Office;
Length of
Time Served
  Principal  Occupation(s)
During Past 5 Years

Theo A. Kolokotrones

225 South Lake Ave.

Pasadena, CA

91101-3005
(1946)

  Co-Chief Executive Officer   Indefinite;
Since 09/04
  Chairman, Director, Portfolio Manager, and Principal
PRIMECAP Management Company

Joel P. Fried

225 South Lake Ave. Pasadena, CA

91101-3005

(1962)

  Co-Chief Executive Officer and Trustee   Indefinite;
Since 09/04
  President, Director, Portfolio Manager, and Principal
PRIMECAP Management Company

 

46


Table of Contents

Management

PRIMECAP Odyssey Funds

 

(Unaudited) – continued

 

Name, Address
(Year of  Birth)
  Position(s)
Held
with Trust
  Term of Office;
Length of
Time Served
  Principal  Occupation(s)
During Past 5 Years

Alfred W. Mordecai

225 South Lake Ave.

Pasadena, CA

91101-3005

(1967)

  Co-Chief Executive Officer   Indefinite;
Since 10/12
 

Executive Vice President, Director, Portfolio Manager, and Principal

PRIMECAP Management Company

Michael J. Ricks

225 South Lake Ave.

Pasadena, CA

91101-3005

(1977)

  Chief Financial Officer, Chief Administrative Officer, and Secretary   Indefinite;
Since 03/11
  Director of Fund Administration PRIMECAP Management Company (since 2011); Vice President, Fund Administration and Compliance, U.S. Bancorp Fund Services, LLC (2001-2011)

Karen Chen

225 South Lake Ave.

Pasadena, CA

91101-3005

(1973)

  Vice President of Compliance, Chief Compliance Officer, and AML Officer   Indefinite;
Since 10/04
  Chief Compliance Officer, Director of Compliance and Reporting
PRIMECAP Management Company

“Independent” Trustees. The table below sets forth certain information about each of the trustees of the Trust who is not an “interested person” of the Trust as defined in the 1940 Act (“Independent Trustees”).

 

Name, Address
(Year of  Birth)
  Position(s)
Held
with Trust
  Term of
Office;
Length of
Time Served
  Principal Occupation(s)
During Past 5 Years
  Number of
Portfolios
in Fund
Complex by
Trustee1
  Other
Director-
ships Held
by Trustee

Benjamin F. Hammon

225 South Lake Ave.

Pasadena, CA

91101-3005

(1935)

  Chairman of the Board and Trustee   Indefinite;
Since 09/04
  Retired; Private investor   3   None

Wayne H. Smith

225 South Lake Ave.

Pasadena, CA

91101-3005

(1941)

  Chairman of the Audit Committee and Trustee   Indefinite;
Since 09/04
  Retired; Private investor   3   None
Joseph G. Uzelac
225 South Lake Ave.
Pasadena, CA
91101-3005
(1944)
  Trustee   Indefinite;
Since 10/07
  Retired; Private investor   3   None
Elizabeth D. Obershaw
225 South Lake Ave.
Pasadena, CA
91101-3005
(1960)
  Trustee   Indefinite;
Since 06/08
  Managing Director, Horsley Bridge Partners, an investment advisor (2007-present)   3   None

 

47


Table of Contents

Management

PRIMECAP Odyssey Funds

 

(Unaudited) – continued

 

“Interested” Trustees. The table below sets forth certain information about each of the trustees of the Trust who is an “interested person” of the Trust as defined by the 1940 Act.

 

Name, Address
(Year of Birth)
  Position(s)
Held
with Trust
  Term of
Office;
Length of
Time Served
  Principal Occupation(s)
During Past 5 Years
  Number of
Portfolios
in Fund
Complex by
Trustee(1)
  Other
Director-
ships Held
by Trustee
Joel P. Fried(2)
225 South Lake Ave.
Pasadena, CA
91101-3005
(1962)
  Co-Chief Executive Officer and Trustee   Indefinite;
Since 09/04
  President, Director, Portfolio Manager, and Principal
PRIMECAP Management Company
  3   None

 

  (1) 

Fund Complex includes any funds, series of funds, or trusts that share the same advisor or that hold themselves out to investors as related companies.

  (2) 

Mr. Fried is an “interested person” of the Trust, as defined by the 1940 Act, because of his employ- ment with PRIMECAP Management Company, the investment advisor to the Trust.

 

48


Table of Contents
LOGO  

Privacy Notice

PRIMECAP Odyssey Funds

 

PRIMECAP Management Company

Maintaining the confidentiality of client personal financial information is very important to PRIMECAP Odyssey Funds (the “Trust”) and PRIMECAP Management Company (the “Advisor”). The Advisor and the Trust may collect several types of nonpublic personal information about investors, including:

 

  •  

Information from forms that investors may fill out and send to the Advisor or the Trust in connection with an account (such as name, address, and social security number).

 

  •  

Information an investor may give the Advisor or the Trust orally.

 

  •  

Information about the amount investors have invested in an account.

 

  •  

Information about any bank account investors may use for transfers between a bank account and a shareholder account.

The Advisor and the Trust will not sell or disclose client personal information to anyone except as permitted or required by law. For example, information collected may be shared with the independent auditors in the course of the annual audit of the Advisor or the Trust. The Advisor or the Trust may also share this information with the Advisor’s or the Trust’s legal counsel, as deemed appropriate, and with regulators. Finally, the Advisor or the Trust may disclose information about clients or investors at the client’s or investor’s request (for example, by sending duplicate account statements to someone designated by the client or investor), or as otherwise permitted or required by law.

Within the Advisor and the Trust, access to information about clients and investors is restricted to those employees or service providers who need to know the information to service client accounts. The Advisor’s employees are trained to follow its procedures to protect client privacy and are instructed to access information about clients only when they have a business reason to obtain it.

The Advisor and the Trust reserve the right to change this privacy policy in the future, but we will not disclose investor nonpublic personal information except as required or permitted by law without giving the investor an opportunity to instruct us not to do so.

 


Table of Contents

Investment Advisor

PRIMECAP MANAGEMENT COMPANY

225 South Lake Avenue, Suite 400

Pasadena, California 91101

 

•

Distributor

QUASAR DISTRIBUTORS, LLC

615 East Michigan Street, 4th Floor

Milwaukee, Wisconsin 53202

 

•

Custodian

THE BANK OF NEW YORK MELLON

One Wall Street

New York, New York 10286

 

•

Transfer Agent

U.S. BANCORP FUND SERVICES, LLC

615 East Michigan Street, 3rd Floor

Milwaukee, Wisconsin 53202

 

•

Administrator

U.S. BANCORP FUND SERVICES, LLC

2020 East Financial Way, Suite 100

Glendora, California 91741

 

•

Legal Counsel

MORGAN, LEWIS & BOCKIUS LLP

355 South Grand Avenue, Suite 4400

Los Angeles, California 90071

 

•

Independent Registered Public Accounting Firm

PRICEWATERHOUSECOOPERS LLP

Three Embarcadero Center

San Francisco, California 94111

This report is intended for the shareholders of the PRIMECAP Odyssey Funds and may not be used as sales literature unless preceded or accompanied by a current prospectus.

Past performance results shown in this report should not be considered a representation of future performance. Share price and returns will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are dated and are subject to change.

PRIMECAP, PRIMECAP Odyssey, and the PRIMECAP Odyssey logo are trademarks of PRIMECAP Management Company.


Table of Contents
Item 2. Code of Ethics.

Not applicable for semi-annual reports.

 

Item 3. Audit Committee Financial Expert.

Not applicable for semi-annual reports.

 

Item 4. Principal Accountant Fees and Services.

Not applicable for semi-annual reports.

 

Item 5. Audit Committee of Listed Registrants.

Not applicable to registrants who are not listed issuers (as defined in Rule 10A-3 under the Securities Exchange Act of 1934).

 

Item 6. Investments.

 

  (a) The registrant’s Schedule of Investments is included as part of the report to shareholders filed under Item 1 of this Form.

 

  (b) Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

 

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to open-end investment companies.

 

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of trustees.


Table of Contents
Item 11. Controls and Procedures.

 

(a) The registrant’s Co-Chief Executive Officers and Chief Financial Officer have reviewed the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded that such disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by other officers of the registrant and by the registrant’s service providers.

 

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12. Exhibits.

 

(a) (1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit. Not applicable for semi-annual reports.

(2) A separate certification for each principal executive and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith.

(3) Any written solicitation to purchase securities under Rule 23c-1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons. Not applicable to open-end investment companies.

 

(b) Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Furnished herewith.

 

2


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PRIMECAP Odyssey Funds
By

/s/ Joel P. Fried

Joel P. Fried, Co-Chief Executive Officer
Date

6/25/15

By

/s/ Theo A. Kolokotrones

Theo A. Kolokotrones, Co-Chief Executive Officer
Date

6/25/15

By

/s/ Alfred W. Mordecai

Alfred W. Mordecai, Co-Chief Executive Officer
Date

6/25/15

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By

/s/ Joel P. Fried

Joel P. Fried, Co-Chief Executive Officer
Date

6/25/15

By

/s/ Theo A. Kolokotrones

Theo A. Kolokotrones, Co-Chief Executive Officer
Date

6/25/15

By

/s/ Alfred W. Mordecai

Alfred W. Mordecai, Co-Chief Executive Officer
Date

6/25/15

By

/s/ Michael J. Ricks

Michael J. Ricks, Chief Financial Officer
Date

6/25/15

 

3